+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 11097

Chapter 11097 contains a list of PDF Full Texts available from EurekaMag.





Vickerstaff Joneja, Janice, M., 1999:
Oral allergy syndrome, cross-reacting allergens and co-occurring allergies

Dodick, David, W., 2001:
Oral almotriptan in the treatment of migraine: Safety and tolerability

Spierings, E.L.; Gomez-Mancilla, B.; Grosz, D.E.; Rowland, C.R.; Whaley, F.S.; Jirgens, K.J., 2001:
Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison

Andersson, K.E.; Stief, C., 2001:
Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction

Jalan, R.; Damink, S.W.M.O.de; Lui, H.F.; Glabus, M.; Deutz, N.E.P.; Hayes, P.C.; Ebmeier, K., 2003:
Oral amino acid load mimicking hemoglobin results in reduced regional cerebral perfusion and deterioration in memory tests in patients with cirrhosis of the liver

Godard, M.P.; Williamson, D.L.; Trappe, S.W., 2002:
Oral amino-acid provision does not affect muscle strength or size gains in older men

Bissonnette, R.; Zeng, H.; Mclean, D.I.; Korbelik, M.; Lui, H., 2001:
Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells

Capucci, A.; Villani, G.Q.; Aschieri, D.; Rosi, A.; Piepoli, M.F., 1999:
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

Pollak, P.Timothy, 1998:
Oral amiodarone: Historical overview and development

Nizankowska, E.; Bestyńska-Krypel, A.; Cmiel, A.; Szczeklik, A., 2000:
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

Lopez, M.E.ena; Bazan, C.; Lorca, I.A.cira; Chervonagura, A., 2002:
Oral and clinical characteristics of a group of patients with Turner syndrome

Baccaglini, L.; Schiffmann, R.; Brennan, M.T.; Lancaster, H.E.; Kulkarni, A.B.; Brahim, J.S., 2001:
Oral and craniofacial findings in Fabry's disease: a report of 13 patients

Zambrano, M.; Nikitakis, N.G.; Sanchez-Quevedo, M.Carmen.; Sauk, J.J.; Sedano, H.; Rivera, H., 2003:
Oral and dental manifestations of vitamin D-dependent rickets type I: report of a pediatric case

Griffin, P.; Mason, H.; Heywood, K.; Cocker, J., 1999:
Oral and dermal absorption of chlorpyrifos: a human volunteer study

Garfitt, S.J.; Jones, K.; Mason, H.J.; Cocker, J., 2002:
Oral and dermal exposure to propetamphos: a human volunteer study

Ikeda, Y.; Yasuno, H.; Sato, A.; Kawai, K., 1998:
Oral and epicutaneous desensitization in urushiol contact dermatitis in guinea pigs sensitized by 2 methods of different sensitizing potency

Gaydos, J.K.; Allison, A.B.; Hanson, B.A.; Yellin, A.S., 2002:
Oral and fecal shedding of epizootic hemorrhagic disease virus, serotype 1 from experimentally infected white-tailed deer

Karimnamazi, H.; Travers, S.P.; Travers, J.B., 2002:
Oral and gastric input to the parabrachial nucleus of the rat

Kwong, P.C.; O'Marcaigh, A.S.; Howard, R.; Cowan, M.J.; Frieden, I.J., 1999:
Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency

Tubaro, A.; Sosa, S.; Carbonatto, M.; Altinier, G.; Vita, F.; Melato, M.; Satake, M.; Yasumoto, T., 2003:
Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice

Prentice, H.G.; Caillot, D.; Dupont, B.; Menichetti, F.; Schuler, U., 1999:
Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: Meeting report(London, England, UK; June 20, 1998;;)

Felder, C.; Uehlinger, C.; Baumann, P.; Powell, K.; Eap, C.B., 1999:
Oral and intravenous methadone use: Some clinical and pharmacokinetic aspects

Kalk, W.W.I.; Mansour, K.; Vissink, A.; Spijkervet, F.K.L.; Bootsma, H.; Kallenberg, C.G.M.; Roodenburg, J.L.N.; Amerongen, A.V.N.euw, 2002:
Oral and ocular manifestations in Sjogren's syndrome

Jensen, J.L.; Bergem, H.O.; Gilboe, I.M.; Husby, G.; Axell, T., 1999:
Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus

Hart, A.K.istina E.; Karakla, D.W.; Pitman, K.T.; Adams, J.F., 1999:
Oral and oropharyngeal squamous cell carcinoma in young adults: A report on 13 cases and review of the literature

Schloerb, P.R.; Skikne, B.S., 1999:
Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study

Li, J.; Farthing, P.M.; Thornhill, M.H., 2000:
Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-alpha and interferon-gamma

Dudas, B.; Cornelli, U.; Lee, J.M.; Hejna, M.J.; Walzer, M.; Lorens, S.A.; Mervis, R.F.; Fareed, J.; Hanin, I., 2002:
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain

Shugars, D.C.; Slade, G.D.; Patton, L.L.; Fiscus, S.A., 2000:
Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

Engstrom, P.E.; George, M.; Larsson, P.; Lally, E.T.; Taichman, N.S.; Norhagen, G.E., 1999:
Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin

Paoluzi, P.; D'albasio, G.; Pera, A.; Porro, G.B.anchi; Paoluzi, O.A.; Pica, R.; Cottone, M.; Miglioli, M.; Prantera, C.; Sturniolo, G.; Ardizzone, S., 2002:
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: One-year randomised multicentre trial

Giltay, E.J.; Verhoef, P.; Gooren, L.J.G.; Geleijnse, J.M.; Schouten, E.G.; Stehouwer, C.D.A., 2003:
Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals

L.R.ux, P.A.; Olarogun, J.O.; Penny, J.; Anthony, J., 2002:
Oral and vaginal misoprostol compared with dinoprostone for induction of labor: A randomized controlled trial

Mitzner, T.L.; Kemper, S., 2003:
Oral and written language in late adulthood: findings from the Nun Study

Leder, B.Z.; Longcope, C.; Catlin, D.H.; Ahrens, B.; Schoenfeld, D.A.; Finkelstein, J.S., 2000 :
Oral androstenedione administration and serum testosterone concentrations in young men

Gin, H.; Rigalleau, V., 2002:
Oral anti diabetic polychemotherapy in type 2 diabetes mellitus

Zuercher, A.W.; Miescher, S.M.; Vogel, M.; Rudolf, M.P.; Stadler, M.B.; Stadler, B.M., 1999:
Oral anti-IgE immunization with epitope-displaying phage

Campbell, E.A.; Gentry, C.; Patel, S.; Kidd, B.; Cruwys, S.; Fox, A.J.; Urban, L., 2000:
Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig

Saleh, T.S.F.; Vianna, R.M.J.; Creczynski Pasa, T.B.; Chakravarty, S.; Mavunkel, B.J.; Kyle, D.J.; Calixto, J.B., 1998:
Oral anti-inflammatory action of NPC 18884, a novel bradykinin B2 receptor antagonist

Macy, E.; Burchette, R.J., 2002:
Oral antibiotic adverse reactions after penicillin skin testing: Multi-year follow-up

Holzheimer, R.G., 2003:
Oral antibiotic prophylaxis can influence the inflammatory response in aortic aneurysm repair: results of a randomized clinical study

Nieuwenhuis, E.E.; Visser, M.R.; Kavelaars, A.; Cobelens, P.M.; Fleer, A.; Harmsen, W.; Verhoef, J.; Akkermans, L.M.; Heijnen, C.J., 2000:
Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli

Bagga, A.; Mantan, M., 2003:
Oral antibiotics for febrile urinary tract infections

Fuller, A.; Mitchell, D., 1999:
Oral antibiotics reduce body temperature of healthy rabbits in a thermoneutral environment

ten Berg, J.M.; Hutten, B.A.; Kelder, J.C.; Verheugt, F.W.; Plokker, H.W., 2001:
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications

Baggio, D.; Madore, F.; Lalonde, G., 2000:
Oral anticoagulant therapy for heart disease: results in actual cardiology practice

Anand, S.S.; Yusuf, S., 1999:
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis

Pengo, V.; Legnani, C.; Noventa, F.; Palareti, G., 2001:
Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study

Cannegieter, S.C.; Torn, M.; Rosendaal, F.R., 1999:
Oral anticoagulant treatment in patients with mechanical heart valves: How to reduce the risk of thromboembolic and bleeding complications

Smith, P., 1999:
Oral anticoagulants are effective long term after acute myocardial infarction

Anand, S.S.; Yusuf, S., 2003:
Oral anticoagulants in patients with coronary artery disease

Froom, P.; Miron, E.; Barak, M., 2003:
Oral anticoagulants in the elderly

Algra, A.; De Schryver, E.L.L.M.; van Gijn, J.; Kappelle, L.J.; Koudstaal, P.J., 2003:
Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin

van Walraven, C.; Hart, R.G.; Singer, D.E.; Laupacis, A.; Connolly, S.; Petersen, P.; Koudstaal, P.J.; Chang, Y.; Hellemons, B., 2002:
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

Arnesen, Harald, 2003:
Oral anticoagulation after myocardial infarction

Copland, M.; Walker, I.D.; Tait, R.C., 2001:
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation

Odén, A.; Fahlén, M., 2002:
Oral anticoagulation and risk of death: a medical record linkage study

Brouwer, M.A.; Verheugt, F.W.A., 2002:
Oral anticoagulation for acute coronary syndromes

Torn, M.; Algra, A.; Rosendaal, F.R., 2001:
Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk

Koefoed, B.G.; Petersen, P., 1999:
Oral anticoagulation in nonvalvular atrial fibrillation

White, R.H.; Mcburnie, M.A.n; Manolio, T.; Furberg, C.D.; Gardin, J.M.; Kittner, S.J.; Bovill, E.; Knepper, L., 1999:
Oral anticoagulation in patients with atrial fibrillation: Adherence with guidelines in an elderly cohort

Kretschmer, G.; Hoelzenbein, T.J., 1999:
Oral anticoagulation in peripheral vascular surgery: How intense, for how long, or at all?

Schulman, S., 1999:
Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings

Fitzmaurice, D.A.; Hobbs, F.D.; Murray, E.T.; Holder, R.L.; Allan, T.F.; Rose, P.E., 2000:
Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial

Simmelink, M.J.A.; de Groot, P.G.; Derksen, R.H.W.M.; Fernandez, Jé.A.; Griffin, J.H., 2002:
Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors

Cromheecke, M.E.; Levi, M.; Colly, L.P.; de Mol, B.J.; Prins, M.H.; Hutten, B.A.; Mak, R.; Keyzers, K.C.; Büller, H.R., 2000:
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison

Brummel, K.E.; Paradis, S.G.; Branda, R.F.; Mann, K.G., 2001:
Oral anticoagulation thresholds

Holmboe, E.S., 2002:
Oral antihyperglycemic therapy for type 2 diabetes: clinical applications

Inzucchi, S.E., 2002:
Oral antihyperglycemic therapy for type 2 diabetes: scientific review

Pasquali, S.K.; Sanders, S.P.; Li, J.S., 2002:
Oral antihypertensive trial design and analysis under the Pediatric Exclusivity Provision

Nishi, J.; Yoshinaga, M.; Tokuda, K.; Masuda, K.; Masuda, R.; Kamenosono, A.; Manago, K.; Miyata, K., 2002:
Oral antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates from Japanese children

D.C.mpos, R.O.P.; Alves, R.V.; Ferreira, J.; Kyle, D.J.; Chakravarty, S.; Mavunkel, B.J.; Calixto, J.B., 1999:
Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist

Ferguson, K., 2001:
Oral appliance therapy for obstructive sleep apnea: finally evidence you can sink your teeth into

Gotsopoulos, H.; Chen, C.; Qian, J.; Cistulli, P.A., 2002:
Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial

Schoem, Scott, R., 2000:
Oral appliances for the treatment of snoring and obstructive sleep apnea

Utzinger, J.; N'Goran, E.K.; N'Dri, A.; Lengeler, C.; Xiao, S.; Tanner, M., 2000:
Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

Vihtamaki, T.; Parantainen, J.; Koivisto, A.M.ija; Metsa Ketela, T.; Tuimala, R., 2002:
Oral ascorbic acid increases plasma oestradiol during postmenopausal hormone replacement therapy

Edwards, J.E.; Oldman, A.D.; Smith, L.A.; Carroll, D.; Wiffen, P.J.; Mcquay, H.J.; Moore, R.A.drew, 1999:
Oral aspirin in postoperative pain: A quantitative systematic review

Tada, A.; Watanabe, T.; Yokoe, H.; Hanada, N.; Tanzawa, H., 2002:
Oral bacteria influenced by the functional status of the elderly people and the type and quality of facilities for the bedridden

Ready, D.; Qureshi, F.; Bedi, R.; Mullany, P.; Wilson, M., 2003:
Oral bacteria resistant to mercury and to antibiotics are present in children with no previous exposure to amalgam restorative materials

Lee, M.C.; Lin, L.H.; Hung, K.L.; Wu, H.Y., 2001:
Oral bacterial therapy promotes recovery from acute diarrhea in children

Gionchetti, P.; Rizzello, F.; Venturi, A.; Brigidi, P.; Matteuzzi, D.; Bazzocchi, G.; Poggioli, G.; Miglioli, M.; Campieri, M., 2000:
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

Cazzola, M.; Calderaro, F.; Califano, C.; D.P.ma, F.; Vinciguerra, A.; Donner, C.F.; Matera, M.G., 1999:
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease

Rizzello, F.; Gionchetti, P.; D'arienzo, A.; Manguso, F.; D.M.tteo, G.; Annese, V.; Valpiani, D.; Casetti, T.; Adamo, S.; Prada, A.; Castiglione, G.N.; Varoli, G.; Campieri, M., 2002:
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: A double-blind placebo-controlled study

Campieri, M.; Adamo, S.; Valpiani, D.; D'arienzo, A.; D'albasio, G.; Pitzalis, M.; Cesari, P.; Casetti, T.; Castiglione, G.N.; Rizzello, F.; Manguso, F.; Varoli, G.; Gionchetti, P., 2003:
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: A multicentre randomised study

Rizzello, F.; Gionchetti, P.; Galeazzi, R.; Novelli, G.; Valpiani, D.; D'arienzo, A.; Manguso, F.; Castiglione, G.; Varoli, G.; Campieri, M., 2001:
Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study

Nagaya, N.; Shimizu, Y.; Satoh, T.; Oya, H.; Uematsu, M.; Kyotani, S.; Sakamaki, F.; Sato, N.; Nakanishi, N.; Miyatake, K., 2002:
Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension

Lievre, M.; Morand, S.; Besse, B.; Fiessinger, J.N.el; Boissel, J.P.erre, 2000:
Oral beraprost sodium, a prostaglandin I2 analogue, for intermittent claudication: A double-blind, randomized, multicenter controlled trial

Plecko, B.; Stoeckler-Ipsiroglu, S.; Schober, E.; Harrer, G.; Mlynarik, V.; Gruber, S.; Moser, E.; Moeslinger, D.; Silgoner, H.; Ipsiroglu, O., 2002:
Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy

Wong, S.F., 2001:
Oral bexarotene in the treatment of cutaneous T-cell lymphoma

Lorenzo-Zúñiga, V.; Bartolí, Rón.; Planas, Rón.; Hofmann, A.F.; Viñado, Bén.; Hagey, L.R.; Hernández, Jé.M.; Mañé, J.; Alvarez, M.A.; Ausina, V.; Gassull, M.Angel., 2003:
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats

Lubbers, N.L.; Polakowski, J.S.; Wegner, C.D.; Burke, S.E.; Diaz, G.J.; Daniell, K.M.; Cox, B.F., 2002:
Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats

Veiga, F.; Fernandes, C.; Teixeira, F., 2000:
Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes

Duan, J.; Liuzzi, M.; Paris, W.; Liard, F.; Browne, A.; Dansereau, N.; Simoneau, B.; Faucher, A-Marie.; Cordingley, M.G., 2003:
Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1

Mamidi, R., N.V.S.; Katneni, K.; Mullangi, R.; Ramanujam, R., 2002:
Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats

Lacy, M.K.; Nicolau, D.P.; Nightingale, C.H.; Geffken, A.; Teng, R.; Vincent, J.; Quintiliani, R., 1999:
Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS

Huang, Yue Wern; Karasov, William, H., 2000:
Oral bioavailability and toxicokinetics of 3,3',4,4',5-pentachlorobiphenyl in northern leopard frogs, Rana pipiens

Evrard, B.; Chiap, P.; DeTullio, P.; Ghalmi, F.; Piel, G.; Van Hees, T.; Crommen, J.; Losson, B.; Delattre, L., 2002:
Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin

D.J.eghere, F.; Allemann, E.; Kubel, F.; Galli, B.; Cozens, R.; Doelker, E.; Gurny, R., 2000:
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: Effect of the particle size and nutritional state

Westphal, K.; Weinbrenner, A.; Giessmann, T.; Stuhr, M.; Franke, G.; Zschiesche, M.; Oertel, R.; Terhaag, B.; Kroemer, H.K.; Siegmund, W., 2000:
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein

Mignot, A.; Guillaume, M.; Göhler, K.; Stahlberg, H-Jürgen., 2002:
Oral bioavailability of gatifloxacin in healthy volunteers under fasting and fed conditions

Shah, A.; Liu, M.C.ung; Vaughan, D.; Heller, A.H., 1999:
Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension

Major, P.P.; Lipton, A.; Berenson, J.; Hortobagyi, G., 2000:
Oral bisphosphonates: A review of clinical use in patients with bone metastases

Kereiakes, Dean, J., 1999:
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: Fact or fancy?

Daley, T.; Birek, C.; Wysocki, G.P., 2000:
Oral bowenoid lesions: differential diagnosis and pathogenetic insights

MacLean, D.; Vissing, J.; Vissing, S.F.; Haller, R.G., 1998:
Oral branched-chain amino acids do not improve exercise capacity in McArdle disease

Wassilew, S.W.; Wutzler, P., 2003:
Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia

Wassilew, S.W.; Wutzler, P., 2003:
Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study

Leuschner, M.; Maier, K.P.ter; Schlichting, J.; Strahl, S.; Herrmann, G.; Dahm, H.H.lmut; Ackermann, H.; Happ, J.; Leuschner, U., 1999:
Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial

Hellers, G.; Cortot, A.; Jewell, D.; Leijonmarck, C.E.ic; Lofberg, R.; Malchow, H.; Nilsson, L.G.ran; Pallone, F.; Pena, S.; Persson, T.; Prantera, C.; Rutgeerts, P.; Group, I.B.desonide Study, 1999:
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease

Angulo, P.; Jorgensen, R.A.; Keach, J.C.; Dickson, E.R.; Smith, C.; Lindor, K.D., 2000:
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Ecker, K.W.; Stallmach, A.; Seitz, G.; Gierend, M.; Greinwald, R.; Achenbach, U., 2003:
Oral budesonide significantly improves water absorption in patients with illeostomy for Crohn disease

Jones, H.E.; Griffiths, R.R., 2002:
Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers

Yurdakok, M.; Aliefendioglu, D.; Yigit, S., 1999:
Oral calcium phosphate in the treatment of neonatal unconjugated hyperbilirubinemia

Fournier, A.; Presne, C.; Oprisiu, R.; Sadek, T., 2002:
Oral calcium, sevelamer and vascular calcification in uraemic patients

Ma'aita, J.K., 2000:
Oral cancer in Jordan: a retrospective study of 118 patients

Balaram, P.; Sridhar, H.; Rajkumar, T.; Vaccarella, S.; Herrero, R.; Nandakumar, A.; Ravichandran, K.; Ramdas, K.; Sankaranarayanan, R.; Gajalakshmi, V.; Muñoz, N.; Franceschi, S., 2002:
Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene

Bouquot, J.E.; Meckstroth, R.L., 1998:
Oral cancer in a tobacco-chewing US population-no apparent increased incidence or mortality

Cruz, G.D.; L.G.ros, R.Z.; Ostroff, J.S.; Hay, J.L.; Kenigsberg, H.; Franklin, D.M.rcedes, 2002:
Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program

Schwartz, S.M.; Daling, J.R.; Doody, D.R.; Wipf, G.C.; Carter, J.J.; Madeleine, M.M.; Mao, E.J.; Fitzgibbons, E.D.; Huang, S.; Beckmann, A.M.; McDougall, J.K.; Galloway, D.A., 1998:
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection

Morritt, A.N.; Mclean, N.R.; Snow, M.H., 2002:
Oral cancer, fever of unknown origin, and listeriosis

Kerawala, C.J., 1999:
Oral cancer, smoking and alcohol: the patients' perspective

Chen Jiangang; Zhong Zhihua; W.X.aoyan; E.A., 2003:
Oral candidiasis in HIV/AIDS patients

Epstein, J.B.; Hancock, P.J.; Nantel, S., 2003:
Oral candidiasis in hematopoietic cell transplantation patients: An outcome-based analysis

Van Cutsem, E.; Twelves, C.; Cassidy, J.; Allman, D.; Bajetta, E.; Boyer, M.; Bugat, R.; Findlay, M.; Frings, S.; Jahn, M.; McKendrick, J.; Osterwalder, B.; Perez-Manga, G.; Rosso, R.; Rougier, P.; Schmiegel, W.H.; Seitz, J.F.; Thompson, P.; Vieitez, J.M.; Weitzel, C.; Harper, P., 2001:
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

Cho, S.Y.; Cheng, A.C.; Cheng, M.C., 2000:
Oral care for children with leukaemia

Rose, L.F.; Mealey, B.; Minsk, L.; Cohen, D.Walter., 2002:
Oral care for patients with cardiovascular disease and stroke

Preston, A.J.; Punekar, S.; Gosney, M.A., 2000:
Oral care of elderly patients: nurses' knowledge and views

Yoneyama, T.; Yoshida, M.; Ohrui, T.; Mukaiyama, H.; Okamoto, H.; Hoshiba, K.; Ihara, S.; Yanagisawa, S.; Ariumi, S.; Morita, T.; Mizuno, Y.; Ohsawa, T.; Akagawa, Y.; Hashimoto, K.; Sasaki, H.; Members, O.T.e Oral Care Working Group, 2002:
Oral care reduces pneumonia in older patients in nursing homes

Frossard, C.P.; Hauser, C.; Eigenmann, P.A., 2001:
Oral carrageenan induces antigen-dependent oral tolerance: prevention of anaphylaxis and induction of lymphocyte anergy in a murine model of food allergy

Jackson, M.S.; Bagg, J.; Gupta, M.N.; Sturrock, R.D., 1999:
Oral carriage of staphylococci in patients with rheumatoid arthritis

Kao, G.D.; Devine, P.; Mirza, N., 1999:
Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy

Karczewska, E.; Konturek, J.E.; Konturek, P.C.; Czesnikiewicz, M.; Sito, E.; Bielanski, W.; Kwiecien, N.; Obtulowicz, W.; Ziemniak, W.; Majka, J.; Hahn, E.G.; Konturek, S.J., 2002:
Oral cavity as a potential source of gastric reinfection by Helicobacter pylori

Nunez Marti, Juan Manuel, 1998:
Oral cavity lesions in leprosy patients

Shenep, J.L.; Flynn, P.M.; Baker, D.K.; Hetherington, S.V.; Hudson, M.M.; Hughes, W.T.; Patrick, C.C.; Roberson, P.K.; Sandlund, J.T.; Santana, V.M.; Sixbey, J.W.; Slobod, K.S., 2000:
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer

Vilaichone, A.; Watana, D.; Chaiwatanarat, T., 2001:
Oral ceftibuten switch therapy for acute pyelonephritis in children

Braga, M.; Cooper, D.S., 2001:
Oral cholecystographic agents and the thyroid

Inoue, H.; Yamamoto, T.; Shoji, A.; Watari, N.; Hirouchi, Y.; Enomoto, M.; Morita, K.'ichi, 1999:
Oral chronic toxicity and carcinogenicity test of polyoxyethylene(10)nonylphenyl ether (NP-10) in female F344 rats

Fellers, G., M.; Green, D.E.rl; Longcore, J., E., 2001:
Oral chytridiomycosis in the mountain yellow-legged frog (Rana muscosa)

Shields, C., L.; Lally, M., R.; Singh, A., D.; Shields, J., A.; Nowinski, T., 1999:
Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis

Franco, Israel, 2000:
Oral cimetidine for the management of genital and perigenital warts in children

Thilagarajah, R.; Witherow, R.O.n.; Walker, M.M., 2001:
Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial

Terg, R.; Cobas, S.; Fassio, E.; Landeira, G.; Rios, B.; Vasen, W.; Abecasis, R.; Rios, H.; Guevara, M., 2000:
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: Results of a multicenter, randomized study

Paganini, H.; Rodriguez Brieshcke, T.; Zubizarreta, P.; Latella, A.; Firpo, V.; Casimir, L.; Armada, A.; Fernandez, C.; Caceres, E.; Debbag, R., 2001:
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia: A Randomized Controlled Trial

Prentice, H.G.ant; Hann, I.M.; Nazareth, B.; Paterson, P.; Bhamra, A.; Kibbler, C.C., 2001:
Oral ciprofloxacin plus colistin: Prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

Leibovitz, E.; Janco, J.; Piglansky, L.; Press, J.; Yagupsky, P.; Reinhart, H.; Yaniv, I.; Dagan, R., 2000:
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children

Petrilli, A.S.rgio; Silva Dantas, L.; Cypriano Campos, M.; Tanaka, C.; Cortez Ginani, V.; Seber, A., 2000:
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial

Davalos, A.; Castillo, J.; Alvarez Sabin, J.; Secades, J.J.; Mercadal, J.; Lopez, S.; Cobo, E.; Warach, S.; Sherman, D.; Clark, W.M.; Lozano, R., 2002:
Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials

Karlsson, K.; Stromberg, M.; Liliemark, J.; Delannoy, A.; Johnson, S.A.N.; Porwit, A.; Kimby, E.; Larfars, G.; Cristiansen, I.; Nilsson, G.; Celsing, F.; Sundstrom, G.; Luthman, M.; Tidefelt, U.; Wallvik, J.; Juliusson, G., 2002:
Oral cladribine for B-cell chronic lymphocytic leukaemia: Report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients

Vieira, A.R., 2003:
Oral clefts and syndromic forms of tooth agenesis as models for genetics of isolated tooth agenesis

Christensen, K.; Olsen, J.; Nørgaard-Pedersen, B.; Basso, O.; Støvring, H.; Milhollin-Johnson, L.; Murray, J.C., 1999:
Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: a population-based case-control study in Denmark, 1991-1994

Kristensen, B.; Ejlertsen, B.; Groenvold, M.; Hein, S.; Loft, H.; Mouridsen, H.T., 1999:
Oral clodronate in breast cancer patients with bone metastases: A randomized study

Pandya, K.J.; Raubertas, R.F.; Flynn, P.J.; Hynes, H.E.; Rosenbluth, R.J.; Kirshner, J.J.; Pierce, H.I.; Dragalin, V.; Morrow, G.R., 2000:
Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study

Shiga, M.; Nishina, K.; Mikawa, K.; Uesugi, T.; Maekawa, N.; Obara, H., 2000:
Oral clonidine premedication does not change efficacy of simulated epidural test dose in sevoflurane-anesthetized children

Gulhas, N.; Turkoz, A.; Durmus, M.; Togal, T.; Gedik, E.; Ersoy, M.O., 2003:
Oral clonidine premedication does not reduce postoperative vomiting in children undergoing strabismus surgery

Goyagi, T.; Tanaka, M.; Nishikawa, T., 1999:
Oral clonidine premedication enhances postoperative analgesia by epidural morphine

Goyagi, T.; Tanaka, M.; Nishikawa, T., 1998:
Oral clonidine premedication enhances the pressor response to ephedrine during spinal anesthesia

Yu, H.P.; Hseu, S.S.; Yien, H.W.; Teng, Y.H.; Chan, K.H., 2003:
Oral clonidine premedication preserves heart rate variability for patients undergoing larparoscopic cholecystectomy

Goyagi, T.; Tanaka, M.; Nishikawa, T., 1999:
Oral clonidine premedication reduces induction dose and prolongs awakening time from propofol-nitrous oxide anesthesia

Goyagi, T.; Tanaka, M.; Nishikawa, T., 2000:
Oral clonidine premedication reduces propofol requirement for laryngeal mask airway insertion

Higuchi, H.; Adachi, Y.; Arimura, S.; Nitahara, K.; Satoh, T., 2002:
Oral clonidine premedication reduces the EC50 of propofol concentration for laryngeal mask airway insertion in male patients

Higuchi, H.; Adachi, Y.; Arimura, S.; Ogata, M.; Satoh, T., 2002:
Oral clonidine premedication reduces the awakening concentration of propofol

Murakami, K.; Mammoto, T.; Kita, T.; Imai, Y.; Mashimo, T.; Kirita, T.; Sugimura, M.; Kishi, Y., 1999:
Oral clonidine reduces the requirement of prostaglandin E1 for induced hypotension

Lau, C.E.; Sun, L.; Wang, Q.; Simpao, A.; Falk, J.L., 2000:
Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context

Labib, R.; Turkall, R.; Abdel Rahman, M.S., 2001:
Oral cocaine produces dose-related hepatotoxicity in male mice

Tao Tao, 1999:
Oral colon drug delivery systems

Lee, S.F.; Halperin, S.A.; Wang, H.; Macarthur, A., 2002:
Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice

Leung, W.K.; Jin, L.J.; Yam, W.C.; Samaranayake, L.P., 2001:
Oral colonization of aerobic and facultatively anaerobic gram-negative rods and cocci in irradiated, dentate, xerostomic individuals

Sarkonen, N.; Könönen, E.; Summanen, P.; Kanervo, A.; Takala, A.; Jousimies-Somer, H., 2000:
Oral colonization with Actinomyces species in infants by two years of age

Remick, S., C.; Sedransk, N.; Haase, R., F.; Blanchard, C., G.; Ramnes, C., R.; Nazeer, T.; Mastrianni, D., M.; Dezube, B., J., 2001:
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: Evaluation of the role of G-CSF; Quality-of-life analysis and long-term follow-up

Xu, B-he.; Zhang, Y-juan.; Zheng, X.; Wu, Q.; Wu, X-ting., 2003:
Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer

Nishimura, K.; Nonomura, N.; Ono, Y.; Nozawa, M.; Fukui, T.; Harada, Y.; Imazu, T.; Takaha, N.; Sugao, H.; Miki, T.; Okuyama, A., 2001:
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer

Charpentier, G., 2002:
Oral combination therapy for type 2 diabetes

Rabbani, L.E.; Seminario, N.A.; Sciacca, R.R.; Chen, H.J.n; Giardina, E.G.ace V., 2002:
Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women

Paulus, D.; Saint Remy, A.; Jeanjean, M., 2000:
Oral contraception and cardiovascular risk factors during adolescence

Vessey, M.; Painter, R., 2001:
Oral contraception and ear disease: Findings in a large cohort study

Vessey, M.; Painter, R.; Yeates, D., 2002:
Oral contraception and epilepsy: Findings in a large cohort study

Plu-Bureau, G.; Bossard, N.; Thalabard, J.C., 2000:
Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies

Vessey, M.; Painter, R.; Mant, J., 1999:
Oral contraception and other factors in relation to back disorders in women: Findings in a large cohort study

Jones, Kirtly Parker, 1999:
Oral contraception: current use and attitudes

Yuzpe, A.Albert., 2002:
Oral contraception: trends over time

Kaunitz, Andrew, M., 1999:
Oral contraceptive health benefits: perception versus reality

Morrison, C.; Prokorym, P.; Piquero, C.; Wakely, P.E.; Nuovo, G.J., 2003:
Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions

Mcintyre, R.; Bigler, L.; Dellinger, T.; Pfeifer, M.; Mannery, T.; Streckfus, C., 1999:
Oral contraceptive usage and the expression of CA 15-3 and c-erbB-2 in the saliva of healthy women

Terry, M.Beth.; Gammon, M.D.; Schoenberg, J.B.; Brinton, L.A.; Arber, N.; Hibshoosh, H., 2002:
Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women

Mathieu, D.; Kobeiter, H.; Maison, P.; Rahmouni, A.; Cherqui, D.; Zafrani, E.S.rge; Dhumeaux, D., 2000 :
Oral contraceptive use and focal nodular hyperplasia of the liver

Troisi, R.J.; Cowie, C.C.; Harris, M.I., 2000:
Oral contraceptive use and glucose metabolism in a national sample of women in the united states

Monster, T.B.; Janssen, W.M.; de Jong, P.E.; de Jong-van den Berg, L.T., 2001:
Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria

Dreon, D., M.; Slavin, J., L.; Phinney, S., D., 2003:
Oral contraceptive use and increased plasma concentration of C-reactive protein

Gammon, M.D.; Hibshoosh, H.; Terry, M.B.; Bose, S.; Schoenberg, J.B.; Brinton, L.A.; Bernstein, J.L.; Thompson, W.D., 1999:
Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women

Newcomer, L.M.; Newcomb, P.A.; Trentham-Dietz, A.; Longnecker, M.P.; Greenberg, E.Robert., 2003:
Oral contraceptive use and risk of breast cancer by histologic type

Italian Endometriosis Study Group, 1999:
Oral contraceptive use and risk of endometriosis

Palmer, J.R.; Driscoll, S.G.; Rosenberg, L.; Berkowitz, R.S.; Lurain, J.R.; Soper, J.; Twiggs, L.B.; Gershenson, D.M.; Kohorn, E.I.; Berman, M.; Shapiro, S.; Rao, R.S., 1999:
Oral contraceptive use and risk of gestational trophoblastic tumors

Cosnes, J.; Carbonnel, F.; Carrat, F.; Beaugerie, L.; Gendre, J.P., 1999:
Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study

Lloyd, T.; Lin, H.M.; Matthews, A.E.; Bentley, C.M.; Legro, R.S., 2002:
Oral contraceptive use by teenage women does not affect body composition

Lloyd, T.; Taylor, D.S.; Lin, H.M.; Matthews, A.E.; Eggli, D.F.; Legro, R.S., 2000:
Oral contraceptive use by teenage women does not affect peak bone mass: A longitudinal study

Kaunitz, Andrew, M., 2001:
Oral contraceptive use in perimenopause

de Vries, E.; den Tonkelaar, I.; van Noord, P.A.; van der Schouw, Y.T.; te Velde, E.R.; Peeters, P.H., 2001:
Oral contraceptive use in relation to age at menopause in the DOM cohort

Prakash, M.; Kapembwa, M.S.; Gotch, F.; Patterson, S., 2002:
Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4+ T cells in the cervical epithelium of healthy women

West, S.G.; Stoney, C.M.; Hughes, J.W.; Matacin, M.; Emmons, K.M., 2001:
Oral contraceptive use is associated with increased cardiovascular reactivity in nonsmokers

Rubino-Watkins, M.F.; Doster, J.A.; Franks, S.; Kelly, K.S.; Sonnier, B.L.; Goven, A.J.; Moorefield, R., 1999:
Oral contraceptive use: implications for cognitive and emotional functioning

Baker, F.C.; Mitchell, D.; Driver, H.S., 2001:
Oral contraceptives alter sleep and raise body temperature in young women

Kuhl, H., 1999:
Oral contraceptives and androgenic symptoms

Pasco, J.A.; Kotowicz, M.A.; Henry, M.J.; Panahi, S.; Seeman, E.; Nicholson, G.C., 2000:
Oral contraceptives and bone mineral density: A population-based study

Spitzer, Walter, O., 2000:
Oral contraceptives and cardiovascular outcomes: Cause or bias?

Fernandez, E.; La Vecchia, C.; Balducci, A.; Chatenoud, L.; Franceschi, S.; Negri, E., 2001:
Oral contraceptives and colorectal cancer risk: a meta-analysis

Sanderson, M.; Williams, M.A.; Weiss, N.S.; Hendrix, N.W.; Chauhan, S.P., 2000:
Oral contraceptives and epithelial ovarian cancer. Does dose matter?

Parkin, L.; Skegg, D.C.; Wilson, M.; Herbison, G.P.; Paul, C., 2000:
Oral contraceptives and fatal pulmonary embolism

Dunn, N.; Thorogood, M.; Faragher, B.; de Caestecker, L.; MacDonald, T.M.; McCollum, C.; Thomas, S.; Mann, R., 1999:
Oral contraceptives and myocardial infarction: results of the MICA case-control study

Lundberg, V.; Asplund, K.; Evrin, P.E.; Eliasson, M., 1998:
Oral contraceptives and oestrogen replacement therapy as determinants of plasma fibrinogen level and fibrinolytic activity: The Northern Sweden MONICA study

Heimdal, K.; Skovlund, E.; Moller, P., 2002:
Oral contraceptives and risk of familial breast cancer

Parazzini, F.; Cipriani, S.; Mangili, G.; Garavaglia, E.; Guarnerio, P.; Ricci, E.; Benzi, G.; Salerio, B.; Polverino, G.; L.V.cchia, C., 2002:
Oral contraceptives and risk of gestational trophoblastic disease

Hernán, M.A.; Hohol, M.J.; Olek, M.J.; Spiegelman, D.; Ascherio, A., 2000:
Oral contraceptives and the incidence of multiple sclerosis

Narod, S.A.; Dube, M.P.erre; Klijn, J.; Lubinski, J.; Lynch, H.T.; Ghadirian, P.; Provencher, D.; Heimdal, K.; Moller, P.; Robson, M.; Offit, K.; Isaacs, C.; Weber, B.; Friedman, E.; Gershoni Baruch, R.; Rennert, G.; Pasini, B.; Wagner, T., 2002:
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Claus, E.B.; Stowe, M.; Carter, D., 2003:
Oral contraceptives and the risk of ductal breast carcinoma in situ

Scalori, A.; Tavani, A.; Gallus, S.; L.V.cchia, C.; Colombo, M., 2002:
Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study

Lidegaard, O.; Bygdeman, M.; Milsom, I.; Nesheim, B.I.gjerd; Skjeldestad, F.E.il; Toivonen, J., 1999:
Oral contraceptives and thrombosis: From risk estimates to health impact

Lidegaard, O.; Edstrom, B.; Kreiner, S., 2002:
Oral contraceptives and venous thromboembolism: A five-year national case-control study

Goto, A.; Reich, M.R.; Aitken, I., 1999:
Oral contraceptives and women's health in Japan

Lacey, J.V.; Brinton, L.A.; Abbas, F.M.; Barnes, W.A.; Gravitt, P.E.; Greenberg, M.D.; Greene, S.M.; Hadjimichael, O.C.; McGowan, L.; Mortel, R.; Schwartz, P.E.; Silverberg, S.G.; Hildesheim, A., 1999:
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas

Mariani, G.; Conard, J.; Bernardi, F.; Bertina, R.; Garcia, V.V.; Prydz, H.; Samama, M.; Sandset, P.M.; Puopolo, M.; Ciarla, M.V.; Poso, R.; D.N.cci, G.D.; Ceci, F.; Marchetti, G., 1999:
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII

Strinic, T.; Eterovic, D., 2003:
Oral contraceptives improve lung mechanics

Chetty, M.; Miller, R., 2001:
Oral contraceptives increase the plasma concentrations of chlorpromazine

Zittermann, A.; Rühl, J.; Berthold, H.K.; Sudhop, T.; van der Ven, H.; Reinsberg, J.; Stehle, P., 2002:
Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations

Sabers, A.; Ohman, I.; Christensen, J.; Tomson, T., 2003:
Oral contraceptives reduce lamotrigine plasma levels

Meresman, G.F.; Auge, L.; Baranao, R.I.; Lombardi, E.; Tesone, M.; Sueldo, C., 2002:
Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis

Hofbauer, R.; Frass, M.; Gmeiner, B.; Salfinger, H.; Salzer, H.; Kos, T.; Wagner, O.; Kapiotis, S.; Kaye, A., D., 1999:
Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers

Khader, Y.S.; Rice, J.; John, L.; Abueita, O., 2003:
Oral contraceptives use and the risk of myocardial infarction: A meta-analysis

Sandoval, D.A.; Maes, D.P.; D'Acquisto, L.; Icenogle, M.; Roach, R.C., 2001:
Oral contraceptives, exercise, and acute mountain sickness in women

Holt, V.L.; Cushing Haugen, K.L.; Daling, J.R., 2003:
Oral contraceptives, tubal sterilization, and functional ovarian cyst risk

Skegg, D.C.G., 2002:
Oral contraceptives, venous thromboembolism, and the courts

Lubianca, J.Neves.; Faccin, C.Sasso.; Fuchs, Fávio.Danni., 2003:
Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women

Sulak, Patricia, J., 1999:
Oral contraceptives: therapeutic uses and quality-of-life benefits--case presentations

Giovagnoni, A.; Fabbri, A.; Maccioni, F., 2002:
Oral contrast agents in MRI of the gastrointestinal tract

Sajeev, C.; Vinay, G.; Archna, R.; Saha, R.N., 2003:
Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose

Rahmaniyan, M.; Johnston, K., E.; Tamura, T., 2003:
Oral copper loading test in humans

Chantler, I.W.; Davie, M.W.J.; Evans, S.F.; Rees, J.S., 2003:
Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service

Wedzicha, J.A., 2000:
Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease

Davies, L.; Angus, R.M.; Calverley, P.M.A., 1999:
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial

Lazenby, J.P.; Guzzo, M.R.; Harding, S.M.; Patterson, P.E.; Johnson, L.F.; Bradley, L.A., 2002:
Oral corticosteroids increase esophageal acid contact times in patients with stable asthma

Felber, S.; Skladal, D.; Wyss, M.; Kremser, C.; Koller, A.; Sperl, W., 2000 :
Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study

Ozer, E.A.un; Yaprak, I.; Atabay, B.; Turker, M.; Aksit, S.; Sarioglu, B., 2000:
Oral cyclic megadose methylprednisolone therapy for chronic immune thrombocytopenic purpura in childhood

Wijdicks, E.F.; Dahlke, L.J.; Wiesner, R.H., 1999:
Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients

Yuhua, L.; Kunyuan, G.; Hui, C.; Yongmei, X.; Chaoyang, S.; Xun, T.; Daming, R., 2001:
Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium

Gomes, J.A.thony; Ip, J.; Santoni Rugiu, F.; Mehta, D.; Ergin, A.; Lansman, S.; Pe, E.; Newhouse, T.T.kle; Chao, S., 1999:
Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study

Prochazka, H.; Sjogren, M.; Agren, H., 2000:
Oral d-fenfluramine test in treatment-refractory depression: Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group

Burger, J.; Snodgrass, J.W., 2000:
Oral deformities in several species of frogs from the Savannah River Site, USA

Gebre-Medhin, G.; Husebye, E., S.; Mallmin, H.; Helstrom, L.; Berne, C.; Karlsson, F.A.ders; Kampe, O., 2000:
Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease

Bowers, L.D., 1999:
Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio

Genazzani, A.D.; Stomati, M.; Strucchi, C.; Puccetti, S.; Luisi, S.; Genazzani, A.R., 2001:
Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women

El-Gibaly, Ibrahim, 2002:
Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery

Darji, A.; Zur Lage, S.; Garbe, A.I.; Chakraborty, T.; Weiss, S., 2000:
Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier

Masuda, K.; Horie, K.; Suzuki, R.; Yoshikawa, T.; Hirano, K., 2002:
Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens

Leone Bay, A.; Sato, M.; Paton, D.; Hunt, A.H.; Sarubbi, D.; Carozza, M.; Chou, J.; Mcdonough, J.; Baughman, R.A., 2001:
Oral delivery of biologically active parathyroid hormone

Joseph, J.W.; Kalitsky, J.; St-Pierre, S.; Brubaker, P.L., 2000:
Oral delivery of glucagon-like peptide-1 in a modified polymer preparation normalizes basal glycaemia in diabetic db/db mice

Hosny, E.A.; A.S.ora, H.I.; Elmazar, M.M.A., 2002:
Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: Effect on relative hypoglycemia of diabetic beagle dogs

Lowman, A.M.; Morishita, M.; Kajita, M.; Nagai, T.; Peppas, N.A., 1999:
Oral delivery of insulin using pH-responsive complexation gels

Lee, Y.K.u; Kim, S.H.e; Byun, Y., 2000:
Oral delivery of new heparin derivatives in rats

Agarwal, V.; Reddy, I.K.; Khan, M.A., 2000:
Oral delivery of proteins: Effect of chicken and duck ovomucoid on the stability of insulin in the presence of alpha-chymotrypsin and trypsin

Ogiso, T.; Funahashi, N.; Tsukioka, Y.; Iwaki, M.; Tanino, T.; Wada, T., 2001:
Oral delivery of synthetic eel calcitonin, elcatonin, in rats

Malingre, M.M.; Beijnen, J.H.; Schellens, J.H.M., 2001:
Oral delivery of taxanes

Niimi, M.; Shirasugi, N.; Hamano, K.; Esato, K.; Matsumoto, K.; Ikeda, Y.; Shatari, T.; Takami, H.; Kodaira, S., 2001:
Oral delivery of xeno-antigen combined with non-depleting anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skin xenograft

Gillott, T.J.; Whallett, A.; Zaphiropoulos, G., 1999:
Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity

Patriarca, G.; Nucera, E.; Roncallo, C.; Pollastrini, E.; Bartolozzi, F.; D.P.squale, T.; Buonomo, A.; Gasbarrini, G.; D.C.mpli, C.; Schiavino, D., 2003:
Oral desensitizing treatment in food allergy: clinical and immunological results

Asplund, R.; Sundberg, B.; Bengtsson, P., 1999:
Oral desmopressin for nocturnal polyuria in elderly subjects: A double-blind, placebo-controlled randomized exploratory study

Kinniburgh, D.; Zhu, H.; Cheng, L.; Kicman, A.T.; Baird, D.T.; Anderson, R.A., 2002:
Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men

Mercorio, F.; D.S.mone, R.; Landi, P.; Sarchianaki, A.; Tessitore, G.; Nappi, C., 2002:
Oral dexketoprofen for pain treatment during diagnostic hysteroscopy in postmenopausal women

Prathanee, B., 1998:
Oral diadochokinetic rate in adults

Bird, P.S.; Huynh, S.C.; Davis, D.; Love, D.N.; Blackall, L.L.; Seymour, G.J., 2002:
Oral disease in animals: The Australian perspective. Isolation and characterisation of black-pigmented bacteria from the oral cavity of marsupials

Veeranna, S.; Raghu, T.Y., 2003:
Oral donovanosis

Ostreikov, I.F.; Pivovarov, S.A.; Milenin, V.V.; Shishkova, M.V.; Vasilyev, Y.I., 1999:
Oral dormicum premedication in children hospitalized in a one-day surgical hospital

Katstra, W.E.; Palazzolo, R.D.; Rowe, C.W.; Giritlioglu, B.; Teung, P.; Cima, M.J., 2000:
Oral dosage forms fabricated by Three Dimensional PrintingTM

Lencioni, M.; Falcone, A.; Allegrini, G.; Pfanner, E.; Masi, G.; Brunetti, I.; D.M.rsico, R.; Fontana, E.; Orlandini, C.; Stampino, C.G.; Bartolozzi, C.; Conte, P.F., 2000:
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study

Ahn, J-Hee.; Kim, T-Won.; Lee, J-Hwan.; Min, Y-Ju.; Kim, J-Gyun.; Kim, J.Cheon.; Yu, C-Sik.; Kim, W.Kun.; Kang, Y-Koo.; Lee, J-Shin., 2003:
Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorin

Miczek, K.A.; de Almeida, R.M., 2001:
Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline

Meisch, Richard, A., 2001:
Oral drug self-administration: An overview of laboratory animal studies

Sandberg, G.E.; Wikblad, K.F., 2003:
Oral dryness and peripheral neuropathy in subjects with type 2 diabetes

Andreassen, O.A.; Meshul, C.K.; Moore, C.; Jørgensen, H.A., 2001:
Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration

Schuurman, H-Jan.; Menninger, K.; Audet, M.; Kunkler, A.; Maurer, C.; Vedrine, C.; Bernhard, M.; Gaschen, L.; Brinkmann, V.; Quesniaux, V., 2002:
Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD

Cohen, L.A.; Aliaga, C.; Pittman, B.; Wynder, E.L., 1999:
Oral enzyme therapy and experimental rat mammary tumor metastasis

Desser, L.; Zavadova, E.; Herbacek, I., 2001:
Oral enzymes as additive cancer therapy

Yildirim, Z.; Sogut, S.; Odaci, E.; Iraz, M.; Ozyurt, H.; Kotuk, M.; Akyol, O., 2003:
Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats

Maganti, K.; Onyemere, K.; Jones, M.P., 2003:
Oral erythromycin and symptomatic relief of gastroparesis: A systematic review

Rosenman, M.B.; Mahon, B.E.; Downs, S.M.; Kleiman, M.B., 2003:
Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis

Shah, N.; Evans, W.S.; Bowers, C.Y.; Veldhuis, J.D., 2000:
Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women

Bracarda, S.; Tonato, M.; Rosi, P.; D.A.gelis, V.; Mearini, E.; Cesaroni, S.; Fornetti, P.; Porena, M., 2000:
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: A phase II study

Zaky Ahel, M.; Kovacic, K.; Kraljic, I.; Tarle, M., 2001:
Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients

Quaglino, A.E.; Craig-Veit, C.B.; Viant, M.R.; Erichsen, A.L.; Fry, D.Michael.; Millam, J.R., 2002:
Oral estrogen masculinizes female zebra finch song system

Vivian, J.A.; Higley, J.D.; Linnoila, M.; Woods, J.H., 1999:
Oral ethanol self-administration in rhesus monkeys: Behavioral and neurochemical correlates

Williams, K.L.; Woods, J.H., 1998:
Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor

Alici, Süleyman.; Saip, P.; Eralp, Yşim.; Aydiner, A.; Topuz, E., 2003:
Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)

Yamaguchi, S.; Wada, T.; Oba, K.; Yoshihiro, S.; Naito, K., 2001:
Oral etoposide following combination chemotherapy and radiation therapy in a patient with advanced adult neuroblastoma led to long survival

Fenig, E.; Brenner, B.; Njuguna, E.; Katz, A.; Schachter, J.; Sulkes, A., 2000:
Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide

Ajani, J.A.; Mansfield, P.F.; Dumas, P., 1999:
Oral etoposide for patients with metastatic gastric adenocarcinoma

Kushner, B.H.; Kramer, K.; Cheung, N.K., 1999:
Oral etoposide for refractory and relapsed neuroblastoma

Drouard, S.; Vigneron, J.; May, I., 1999:
Oral etoposide: Form for better pediatric compliance

Farb, A.; John, M.; Acampado, E.; Kolodgie, F.D.; Prescott, M.Forney.; Virmani, R., 2002:
Oral everolimus inhibits in-stent neointimal growth

Yamanaka, K.; Takabayashi, F.; Mizoi, M.; An, Y.; Hasegawa, A.; Okada, S., 2001:
Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis

Geyer, T.E.; Foy, M.A., 2001:
Oral extrusion of a screw after anterior cervical spine plating

Lau, C.; Schanler, R.J., 2000:
Oral feeding in premature infants: advantage of a self-paced milk flow

Zavazava, N.; Fändrich, F.; Zhu, X.; Freese, A.; Behrens, D.; Yoo-Ott, K.A., 2000:
Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination

Subramanian, S.; Matejuk, A.; Zamora, A.; Vandenbark, A.A.; Offner, H., 2003:
Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system

Gron, B.; Stoltze, K.; Andersson, A.; Dabelsteen, E., 2002:
Oral fibroblasts produce more HGF and KGF than skin fibroblasts in response to co-culture with keratinocytes

van Oijen, M.G.; Slootweg, P.J., 2000:
Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?

Khidir, K.T.resa; Renaud, C., B., 2003:
Oral fimbriae and papillae in parasitic lampreys (Petromyzontiformes)

Fukui, N.; Amano, A.; Akiyama, S.; Daikoku, H.; Wakisaka, S.; Morisaki, I., 2000:
Oral findings in DiGeorge syndrome: clinical features and histologic study of primary teeth

Celenk, P.; Arici, S.; Celenk, C., 2003:
Oral findings in a typical case of achondroplasia

Meyer, U.; Kleinheinz, J.; Handschel, J.; Kruse Loesler, B.; Weingart, D.; Joos, U., 2000:
Oral findings in three different groups of immunocompromised patients

Domingues, L.M.; Alessi, A.C.; Schoken Iturrino, R.P.; Dutra, L.S., 1999:
Oral flora asssociated with periodontal disease in dogs

Temple, Christine, M., 2002:
Oral fluency and narrative production in children with Turner's syndrome

Marshall, B.; Howat, A.J.; Wright, P.A., 1999:
Oral fluid antibody detection in the diagnosis of Helicobacter pylori infection

O'Connell, T.; Thornton, L.; O'Flanagan, D.; Staines, A.; Connell, J.; Dooley, S.; McCormack, G., 2001:
Oral fluid collection by post for viral antibody testing

Osugi, H.; Takada, N.; Takemura, M.; Kaseno, S.; Lee, S.; Ueno, M.; Tanaka, Y.; Fukuhara, K.; Fujiwara, Y.; Kinoshita, H., 2002:
Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination

Leonard, R.C., 2001:
Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer

Adimi, P.; Hansen, F.; Kjaer, M.; Aabo, K.; Keldsen, N.; Pfeiffer, P.; Sandberg, E.; Jakobsen, A., 2002:
Oral fluoropyrimidines in the treatment of advanced colorectal cancer: Results of two consecutive phase II trials

Macdonald, J.S., 1999:
Oral fluoropyrimidines: a closer look at their toxicities

Iezzi, G.; Rubini, C.; Fioroni, M.; Piattelli, A., 2001:
Oral focal mucinosis of the gingiva: case report

Feng, F.-Yi; Zhang, P.; He, Y.-Jian; Li, Y.-Hong; Zhou, M.-Zhen; Cheng, G.; Chen, Y.; Kikkawa, T.; Yamamoto, M., 2002:
Oral formulations of the selective serotonin3 antagonists ramosetron (intraoral disintegrator formulation) and granisetron hydrochloride (standard tablet) in treating acute chemotherapy-induced emesis, nausea, and anorexia: A multicenter, randomized, single-blind, crossover, comparison study

Kuspis, D.A.; Krenzelok, E.P., 1999:
Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon

Galmarini, C.M.; Garbovesky, C.; Galmarini, D.; Galmarini, F.C., 2003:
Oral ftorafur plus intramuscular thiotepa as adjuvant chemotherapy in patients with breast cancer

Shinkai, R.S.A.; Hatch, J.P.; Sakai, S.; Mobley, C.C.; Saunders, M.J.; Rugh, J.D., 2001:
Oral function and diet quality in a community-based sample

Al-Mohaya, M.Ali.; Darwazeh, A.; Al-Khudair, W., 2002:
Oral fungal colonization and oral candidiasis in renal transplant patients: the relationship to Miswak use

Chang, S.C.wen; Hsieh, S.M.n; Chen, M.L.n; Sheng, W.H.ei; Chen, Y.C.un, 2000:
Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains

Pescovitz, M.D.; Pruett, T.L.; Gonwa, T.; Brook, B.; McGory, R.; Wicker, K.; Griffy, K.; Robinson, C.A.; Jung, D., 1998:
Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function

Martin, D.F.; Kuppermann, B.D.; Wolitz, R.A.; Palestine, A.G.; Li, H.; Robinson, C.A.; Roche Ganciclovir Study Group, 1999:
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant

Bozkaya, H.; Yurdaydin, C.; Bozdayi, A.Mithat.; Erkan, O.; Karayalcin, S.; Uzunalimoglu, O., 2002:
Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study

Mouly, S.; Aymard, G.; Diquet, B.; Caulin, C.; Bergmann, J.F., 2000:
Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss

Hadziyannis, S.J.; Manesis, E.K.; Papakonstantinou, A., 1999:
Oral ganciclovir treatment in chronic hepatitis B virus infection: A pilot study

Gotfried, M.; Quinn, T.C.; Gothelf, S.; Wikler, M.A.; Webb, C.D.uglas; Nicholson, S.C., 2002:
Oral gatifloxacin in outpatient community-acquired pneumonia: Results from TeqCES, a community-based, open-label, multicenter study

Lode, H.; File, T.M.J.; Mandell, L.; Ball, P.; Pypstra, R.; Thomas, M.; 185 Gemifloxacin Study Group, 2002:
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability

Khoo, C.G.L.; Frantzich, S.; Rosinski, A.; Sjostrom, M.; Hoogstraate, J., 2003:
Oral gingival delivery systems from chitosan blends with hydrophilic polymers

Landstedt-Hallin, L.; Adamson, U.; Lins, P.E., 1999:
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes

Eriksson, M.; Gradin, M.; Schollin, J., 1999:
Oral glucose and venepuncture reduce blood sampling pain in newborns

Heptulla, R.A.; Tamborlane, W.V.; Ma, T.Y.; Rife, F.; Sherwin, R.S., 2001:
Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans

Title, L.M.; Cummings, P.M.; Giddens, K.; Nassar, B.A., 2000:
Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E

Negoro, M.; Nakagaki, H.; Tsuboi, S.; Adachi, K.; Hanaki, M.; Tanaka, D.; Takami, Y.; Nakano, T.; Kuwahara, M.; Thuy, T.T.u, 2000:
Oral glucose retention, saliva viscosity and flow rate in 5-year-old children

Crowe, S.M.; Mastrobattista, J.M.; Monga, M., 2000:
Oral glucose tolerance test and the preparatory diet

Kaji, H.; Morita, E.; Ikeda, M.; Hino, Y.; Tsutsui, T.; Murata-Kamiya, N., 2001:
Oral glucose tolerance test in sixty gastrectomized subjects with reference to oxyhyperglycemia

Beuschlein, F.; Borgemeister, M.; Schirra, J.; Goke, B.; Fassnacht, M.; Arlt, W.; Allolio, B.; Reincke, M., 2000:
Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas

Cockerham, M.B.; Weinberger, B.B.; Lerchie, S.B., 2000:
Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation

Canovas, G.; León-Sanz, M.; Gómez, P.; Valero, M.A.; Gomis, P.; L.H.erta, J.J., 2000:
Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels

Huang, E.Y.n; Leung, S.W.n; Wang, C.J.ng; Chen, H.C.un; Sun, L.M.n; Fang, F.M.n; Yeh, S.A.; Hsu, H.C.ih; Hsiung, C.Y.h, 2000:
Oral glutamine to alleviate radiation-induced oral mucositis: A pilot randomized trial

Catella Lawson, F.; Kapoor, S.; Moretti, D.; D.M.rco, S.; Vigilante, G.J.; Cucchiara, A.J.; Ramsey, K.E.; Combe, S.; Rocca, B.; Theroux, P.; Fitzgerald, G.A.; Afirme Investigators, 2001:
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease

Cannon, C.P.; McCabe, C.H.; Wilcox, R.G.; Langer, A.; Caspi, A.; Berink, P.; Lopez-Sendon, J.; Toman, J.; Charlesworth, A.; Anders, R.J.; Alexander, J.C.; Skene, A.; Braunwald, E., 2000:
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

Leebeek, F.W.G.; Boersma, E.; Cannon, C.P.; van de Werf, F.J.J.; Simoons, M.L., 2002:
Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable

Darius, Harald, 2001:
Oral glycoprotein IIb/IIa antagonists for unstable angina: Is there still a chance for the oral substances?

Van Poznak, C.; Seidman, A.D.; Reidenberg, M.M.; Moasser, M.M.; Sklarin, N.; Van Zee, K.; Borgen, P.; Gollub, M.; Bacotti, D.; Yao, T.J.; Bloch, R.; Ligueros, M.; Sonenberg, M.; Norton, L.; Hudis, C., 2001:
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial

Munro, H.M.; D'Errico, C.C.; Lauder, G.R.; Wagner, D.S.; Voepel-Lewis, T.; Tait, A.R., 1999:
Oral granisetron for strabismus surgery in children

Mabro, M.; Cohn, R.; Zanesco, L.; Madon, E.; Hahlen, K.; Margueritte, G.; Breatnach, F.; Gentet, J.C.aude; Plouvier, E., 2000:
Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: Double-blind study of two doses

Wurapa, A.K.; Luque, A.E.; Menegus, M.A., 1999:
Oral hairy leukoplakia: a manifestation of primary infection with Epstein-Barr virus?

Guccion, J.G.; Redman, R.S., 1999:
Oral hairy leukoplakia: an ultrastructural study and review of the literature

Dias, E.P.; Rocha, M.L.; Silva JúniorA.S.yrides, K.S.; Ferreira, S.M.; Polignano, G.A.; Feijó, E.C.; D.F.nseca, E.C., 2000:
Oral hairy leukoplakia. Histopathologic and cytopathologic features of a subclinical phase

Mickenautsch, S.; Rudolph, M.J.; Ogunbodede, E.O.; Chikte, U.M., 1999:
Oral health among Liberian refugees in Ghana

Meurman, J.H.; Qvarnström, M.; Janket, S-Ja.; Nuutinen, P., 2003:
Oral health and health behavior in patients referred for open-heart surgery

Sandberg, G.E.; Wikblad, K.F., 2003:
Oral health and health-related quality of life in type 2 diabetic patients and non-diabetic controls

Walton, A.G.; Welbury, R.R.; Thomason, J.M.; Foster, H.E., 2000:
Oral health and juvenile idiopathic arthritis: a review

Hung, H.C.ia; Willett, W.; Merchant, A.; Rosner, B.A.; Ascherio, A.; Joshipura, K.J., 2003:
Oral health and peripheral arterial disease

Narang, A.; Maguire, A.; Nunn, J.H.; Bush, A., 2003:
Oral health and related factors in cystic fibrosis and other chronic respiratory disorders

Ramon, T.; Grinshpoon, A.; Zusman, S.P.; Weizman, A., 2003:
Oral health and treatment needs of institutionalized chronic psychiatric patients in Israel

Nunn, J.H.; Sharp, J.; Lambert, H.J.; Plant, N.D.; Coulthard, M.G., 2000:
Oral health in children with renal disease

Pajukoski, H.; Meurman, J.H.; Snellman Grohn, S.; Sulkava, R., 1999:
Oral health in hospitalized and nonhospitalized community-dwelling elderly patients

Lichota, Damian, 1998:
Oral health in the Polish adults population aged 35-44 years

Tuominen, R.; Reunanen, A.; Paunio, M.; Paunio, I.; Aromaa, A., 2003:
Oral health indicators poorly predict coronary heart disease deaths

Drummond, B.K.; Clarke, H.M.; Maxwell Mcrae, A.M.; Konthasinghe, P.P.; Thomson, W.M.rray, 2002:
Oral health knowledge of Plunket nurses in New Zealand: Evaluaton of an oral health module

Oliveira, E.R.; Narendran, S.; Williamson, D., 2000:
Oral health knowledge, attitudes and preventive practices of third grade school children

Cutando, A.; Gil, J.A.; López, J., 2000:
Oral health management implications in patients with tuberous sclerosis

Bourgeois, D.; Berger, P.; Hescot, P.; Leclercq, M.H.; Doury, J., 1999:
Oral health status in 65-74 years old adults in France, 1995

Vargas, C.M.; Yellowitz, J.A.; Hayes, K.L., 2003:
Oral health status of older rural adults in the United States

Welt, F.G.; Woods, T.C.; Edelman, E.R., 2001:
Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injury

Gavaler, J.S., 2002:
Oral hormone replacement therapy: factors that influence the estradiol concentrations achieved in a multiracial study population

Charmandari, E.; Pincus, S.M.; Matthews, D.R.; Johnston, A.; Brook, C.G.D.; Hindmarsh, P.C., 2002:
Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion

Peñarrocha, M.; Sanchis, J.M.; Sáez, U.; Gay, C.; Bagán, J.V., 2001:
Oral hygiene and postoperative pain after mandibular third molar surgery

Nunez Marti, Juan Manuel, 1998:
Oral hygiene in leprosy patients

Merchant, A.; Pitiphat, W.; Douglass, C.W.; Crohin, C.; Joshipura, K., 2002:
Oral hygiene practices and periodontitis in health care professionals

Talamini, R.; Vaccarella, S.; Barbone, F.; Tavani, A.; L.V.cchia, C.; Herrero, R.; Muñoz, N.; Franceschi, S., 2000:
Oral hygiene, dentition, sexual habits and risk of oral cancer

Bytzer, P.; Talley, N.J.; Jones, M.P.; Horowitz, M. , 2001:
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus

Raptis, S.A.; Dimitriadis, G.D., 2001:
Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers

Horimoto, H.; Nakai, Y.; Mieno, S.; Nomura, Y.; Nakahara, K.; Sasaki, S., 2002:
Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning

Tanko, L.B.; Mouritzen, U.; Lehmann, H.J.; Warming, L.; Moelgaard, A.; Christgau, S.; Qvist, P.; Baumann, M.; Wieczorek, L.; Hoyle, N.; Christiansen, C., 2003:
Oral ibandronate: Changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens

Cox, E.; Van der Stede, Y.; Verdonck, F.; Snoeck, V.; Van den Broeck, W.; Goddeeris, B., 2002:
Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms

Kaden, V.; Lange, E.; Fischer, U.; Strebelow, G., 2000:
Oral immunisation of wild boar against classical swine fever: evaluation of the first field study in Germany

Conacher, M.; Alexander, J.; Brewer, J., M., 2001:
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)

Wandeler, A.I., 2000:
Oral immunization against rabies: afterthoughts and foresight

Katz, D., E.; Delorimier, A., J.; Wolf, M., K.; Hall, E., R.; Cassels, F., J.; Van-Hamont, J., E.; Newcomer, R., L.; Davachi, M., A.; Taylor, D., N.; Mcqueen, C., E., 2003:
Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

Conlan, J.W.; KuoLee, R.; Webb, A.; Cox, A.D.; Perry, M.B., 2000:
Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen

Liu, X.; Hu, J.; Zhang, X.; Fan, D., 2002:
Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit

Kende, M.; Yan, C.; Hewetson, J.; Frick, M.A.; Rill, W.L.; Tammariello, R., 2002:
Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge

Wedemeyer, H.; Gagneten, S.; Davis, A.; Bartenschlager, R.; Feinstone, S.; Rehermann, B., 2001:
Oral immunization with HCV-NS3-transformed Salmonella: Induction of HCV-specific CTL in a transgenic mouse model

Lundin, B.Samuel.; Johansson, C.; Svennerholm, A-Mari., 2002:
Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans

de Weerd, N.; Bhalla, P.L.; Singh, M.B., 2003:
Oral immunization with a recombinant major grass pollen allergen induces blocking antibodies in mice

Vogel, K.; Kantor, J.; Wood, L.; Rivera, R.; Schlom, J., 1998:
Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses

Myers, G.A.; Ermak, T.H.; Georgakopoulos, K.; Tibbitts, T.; Ingrassia, J.; Gray, H.; Kleanthous, H.; Lee, C.K.; Monath, T.P., 1999:
Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection

Sharma, A.; Honma, K.; Evans, R.T.; Hruby, D.E.; Genco, R.J., 2001:
Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains

Gundel, I.; Weidinger, G.; ter Meulen, V.; Heesemann, Jürgen.; Rüssmann, H.; Niewiesk, S., 2003:
Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis

Matsunaga, Y.; Wakatsuki, Y.; Tabata, Y.; Kawasaki, H.; Usui, T.; Yoshida, M.; Itoh, T.; Habu, S.; Kita, T., 2000:
Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization

Michetti, P.; Kreiss, C.; Kotloff, K.L.; Porta, N.; Blanco, J.L.is; Bachmann, D.; Herranz, M.; Saldinger, P.F.; Corthesy Theulaz, I.; Losonsky, G.; Nichols, R.; Simon, J.; Stolte, M.; Ackerman, S.; Monath, T.P.; Blum, A.L., 1999:
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

Yeh, M.K.ng; Liu, Y.T.en; Chen, J.L.ng; Chiang, C.H.i, 2002:
Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles

Lekholm, U.; Wannfors, K.; Isaksson, S.; Adielsson, B., 1999:
Oral implants in combination with bone grafts. A 3-year retrospective multicenter study using the Branemark implant system

Oriol, A.; Ribera, J-Maria.; Brunet, S.; Esteve, J.; Bueno, J.; Llorente, Aés., 2003:
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia

Liesenfeld, O., 2002:
Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?

Cross, M.L.; Labes, R.E.; Mackintosh, C.G., 2000:
Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response

Lalla, E.; Lamster, I.B.; Hofmann, M.A.; Bucciarelli, L.; Jerud, A.P.; Tucker, S.; Lu, Y.; Papapanou, P.N.; Schmidt, A.Marie., 2003:
Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice

Meurman, Jukka, H., 2000:
Oral infections and general health with special emphasis on the wisdom tooth problem in soldiers

Aattour, N.; Bouras, M.; Tome, D.; Marcos, A.; Lemonnier, D., 2002:
Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-gamma production

Chaillous, L.; Lefevre, H.; Thivolet, C.; Boitard, C.; Lahlou, N.; Atlan Gepner, C.; Bouhanick, B.; Mogenet, A.; Nicolino, M.; Carel, J.C.aude; Lecomte, P.; Marechaud, R.; Bougneres, P.; Charbonnel, B.; Sai, P., 2000:
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: A multicentre randomised controlled trial

Pozzilli, P.; Cavallo, M.G.sella, 2000:
Oral insulin and the induction of tolerance in man: Reality or fantasy?

Shamir, R.; Shehadeh, N.; Rosenblat, M.; Eshach-Adiv, O.; Coleman, R.; Kaplan, M.; Hamoud, S.; Lischinsky, S.; Hayek, T., 2003:
Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice

Schwaibold, H.; Popiel, C.; Geist, E.; Hartung, R., 2001:
Oral intake of poppy seed: A reliable and simple method for diagnosing vesico-enteric fistula

Polman, C.; Barkhof, F.; Kappos, L.; Pozzilli, C.; Sandbrink, R.; Dahlke, F.; Jakobs, P.; Lorenz, A., 2003:
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

Kabat-Koperska, J.; Herdzik, E.; Safranow, K.; Myślak, M.; Domański, L.; Rózański, J.; Ciechanowski, K., 2003 :
Oral iron absorption test: should it be performed before starting treatment with ferrous preparations?

Kivivuori, S.M.; Virtanen, M.; Raivio, K.O.; Viinikka, L.; Siimes, M.A., 1999:
Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants

Dessirier, J.M.; O'mahony, M.; Carstens, E., 2001:
Oral irritant properties of menthol: Sensitizing and desensitizing effects of repeated application and cross-desensitization to nicotine

Dessirier, J.M.; O'mahony, M.; Iodi Carstens, M.; Yao, E.; Carstens, E., 2001:
Oral irritation by sodium chloride: Sensitization, self-desensitization, and cross-sensitization to capsaicin

Reich, S.; Bührer, C.; Henze, G.; Ohlendorf, D.; Mesche, M.; Sinha, P.; Kage, A.; Müller, C.; Vetter, B.; Kulozik, A.E., 2000:
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia

Ophof, R.; Van Rheden, R.E.M.; Von Den Hoff, J.W.; Schalkwijk, J.; Kuijpers Jagtman, A.M., 2002:
Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue

Lauretti, G.R.; Lima, I.C.; Reis, M.P.; Prado, W.A.; Pereira, N.L., 1999:
Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management

Shewale, S.; Saxena, A.; Trikha, A.; Singh, M.; Sharief, A., 2000:
Oral ketamine for radiotherapy in children with cancer

Shimoyama, M.; Shimoyama, N.; Gorman, A.L.urel; Elliott, K.J.; Inturrisi, C.E., 1999:
Oral ketamine is antinociceptive in the rat formalin test: Role of the metabolite, norketamine

Auden, S.M.; Sobczyk, W.L.; Solinger, R.E.; Goldsmith, L.J., 2000:
Oral ketamine/midazolam is superior to intramuscular meperidine, promethazine, and chlorpromazine for pediatric cardiac catheterization

Vermeulen, A.; Hoekstra, C.; Brokx, J.; Van Den Broek, P., 1999:
Oral language acquisition in children assessed with the Reynell developmental language scales

Castro, D.C.; Lubker, B.B.; Bryant, D.M.; Skinner, M., 2002:
Oral language and reading abilities of first-grade Peruvian children: Associations with child and family factors

Das, D.K.; Grover, R.K.; Anand, V.J.; Mandal, A.K.; Jain, S.; Jain, J.; Bhat, N.C.; Chowdhury, V., 1999:
Oral leiomyosarcoma in childhood. Report of a case with fine needle aspiration cytology

Koch, P.; Bahmer, F.A., 1999:
Oral lesions and symptoms related to metals used in dental restorations: A clinical, allergological, and histologic study

Nicolatou, O.; Theodoridou, M.; Mostrou, G.; Velegraki, A.; Legakis, N.J., 1999:
Oral lesions in children with perinatally acquired human immunodeficiency virus infection

Brice, D.M.; Danesh-Meyer, M.J., 2001:
Oral lesions in patients with psoriasis: clinical presentation and management

Scully, C.; Gokbuget, A.Y.; Allen, C.; Bagan, J.V.; Efeoglu, A.; Erseven, G.; Flaitz, C.; Cintan, S.; Hodgson, T.; Porter, S.R.; Speight, P., 2001:
Oral lesions indicative of plasminogen deficiency (hypoplasminogenemia)

Martin, G.C.; Brown, J.P.; Eifler, C.W.; Houston, G.D., 1999:
Oral leukoplakia status six weeks after cessation of smokeless tobacco use

Harjola, V.P.kka; Peuhkurinen, K.; Nieminen, M.S.; Niemela, M.; Sundberg, S., 1999:
Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure

Bhushan, M.; Burden, A.D.; Mcelhone, K.; James, R.; Vanhoutte, F.P.; Griffiths, C.E.M., 2001:
Oral liarozole in the treatment of palmoplantar pustular psoriasis: A randomized, double-blind, placebo-controlled study

Ogmundsdottir, H.M.; Hilmarsdottir, H.; Astvaldsdottir, A.; Johannsson, J.H.ioar; Holbrook, W.P.ter, 2002:
Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in Iceland

Carrozzo, M.; Gandolfo, S.; Lodi, G.; Carbone, M.; Garzino Demo, P.; Carbonero, C.; Porter, S.R.; Scully, C., 1999:
Oral lichen planus in patients infected or noninfected with hepatitis C virus: The role of autoimmunity

Pilli, M.; Penna, A.; Zerbini, A.; Vescovi, P.; Manfredi, M.; Negro, F.; Carrozzo, M.; Mori, C.; Giuberti, T.; Ferrari, C.; Missale, G., 2002:
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response

Chaiyarit, P.; Kafrawy, A., H.; Miles, D., A.; Zunt, S., L.; Van-Dis, M., L.; Gregory, R., L., 1999:
Oral lichen planus: An immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis

Mignogna, M.D.; L.M.zio, L.; L.R.sso, L.; Fedele, S.; Ruoppo, E.; Bucci, E., 2000:
Oral lichen planus: Different clinical features in HCV-positive and HCV-negative patients

Dorrego, M.V.llarroel; Correnti, M.; Delgado, R.; Tapia, F.J., 2002:
Oral lichen planus: Immunohistology of mucosal lesions

Chainani-Wu, N.; Silverman, S.; Lozada-Nur, F.; Mayer, P.; Watson, J.J., 2001:
Oral lichen planus: patient profile, disease progression and treatment responses

Epstein, J.B.; Wan, L.S.; Gorsky, M.; Zhang, L., 2003:
Oral lichen planus: Progress in understanding its malignant potential and the implications for clinical management

Buajeeb, W.; Kraivaphan, P.; Punyasingh, J.; Laohapand, P., 1999:
Oral lichen sclerosus et atrophicus: A case report

Wong, L.; Freeman, S., 2003:
Oral lichenoid lesions (OLL) and mercury in amalgam fillings

Pemberton, M.N.; Sloan, P.; Thakker, N.S., 2000:
Oral lichenoid lesions after hepatitis B vaccination

Lim, D.S.; Muir, J., 2002:
Oral lichenoid reaction to imatinib (STI 571, Gleevec)

Dunsche, A.; Kaestel, I.; Terheyden, H.; Springer, I.N.G.; Christophers, E.; Brasch, J., 2003:
Oral lichenoid reactions associated with amalgam: Improvement after amalgam removal

Khan, Ijaz, A., 2003:
Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

Beltrutti, D.; Collura, C.; Lamberto, A., 1998:
Oral lorazepam as premedication decreases the perioperative pain experience in knee arthroscopical meniscectomy under selective spinal anaesthesia

Li, J.; French, B.A.; Riley, N.; Bardag-Gorce, F.; Fu, P.; French, S.W., 2001:
Oral low-carbohydrate alcohol liquid diet induces experimental steatohepatitis in the rat

Guideri, F.; Capecchi, P.L.opoldo; Acampa, M.; Cuomo, A.; Lazzerini, P.E.ea; D.G.orgi, L.; Pasini, F.L.ghi, 2002:
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study

Guo Yin Shi; Y.H.i Jian; Xin, Z.L.n, 2002:
Oral low-dose etoposide for advanced non-small-cell lung cancer

Salartash, K.; Gonze, M.D.; Leone Bay, A.; Baughman, R.; Sternbergh, W.C.arles, IIi; Money, S.R., 1999:
Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat

Flaitz, C.M., 2000:
Oral lymphoepithelial cyst in a young child

Fogarty, A.; Lewis, S.A.; Scrivener, S.L.; Antoniak, M.; Pacey, S.; Pringle, M.; Britton, J., 2003:
Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial

Trauninger, A.; Pfund, Z.; Koszegi, T.; Czopf, J., 2002:
Oral magnesium load test in patients with migraine

Wang, F.; Van Den Eeden, S.K.; Ackerson, L.M.; Salk, S.E.; Reince, R.H.; Elin, R.J., 2003:
Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double-blind, placebo-controlled trial

D.F.anceschi, L.; Bachir, D.; Galacteros, F.; Tchernia, G.; Cynober, T.; Neuberg, D.; Beuzard, Y.; Brugnara, C., 2000:
Oral magnesium pidolate: Effects of long-term administration in patients with sickle cell disease

Shechter, M.; Sharir, M.; Labrador, M.J.; Forrester, J.; Silver, B.; Bairey Merz, C.N., 2000:
Oral magnesium therapy improves endothelial function in patients with coronary artery disease

Paryavi-Gholami, F.; Minah, G.E.; Turng, B.F., 1999:
Oral malodor in children and volatile sulfur compound-producing bacteria in saliva: preliminary microbiological investigation

Shaw, M.J.; Kumar, N.D.; Duggal, M.; Fiske, J.; Lewis, D.A.; Kinsella, T.; Nisbet, T., 2000:
Oral management of patients following oncology treatment: literature review

Ariyawardana, S.P.; Hay, K.D., 1999:
Oral manifestations and dental management of immunocompromised patients

Kho, H.S.; Lee, S.W.; Chung, S.C.; Kim, Y.K., 1999:
Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis

Ramirez Amador, V.; Esquivel Pedraza, L.; Caballero Mendoza, E.; Berumen Campos, J.; Orozco Topete, R.; Angeles Angeles, A., 1999:
Oral manifestations as a hallmark of malignant acanthosis nigricans

Reichart, P.A., 2003:
Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma

Brennan, M.T.; Sankar, V.; Baccaglini, L.; Pillemer, S.R.; Kingman, A.; Nunez, O.; Young, N.S.; Atkinson, J.C., 2001:
Oral manifestations in patients with aplastic anemia

Tsang, P.C.S.; Samaranayake, L.P., 1999:
Oral manifestations of HIV infection in a group of predominantly ethnic Chinese

Anteyi, K.O.; Thacher, T.D.; Yohanna, S.; Idoko, J.I., 2003:
Oral manifestations of HIV-AIDS in Nigerian patients

Murakami, A.; Skovby, F.; Andreasen, J.O.; Cohen, M.M.; Jensen, B.L.; Kreiborg, S., 1999:
Oral manifestations of Schimmelpenning syndrome: case report and review of literature

Wu, J.; Fantasia, J.E.; Kaplan, R., 2002:
Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias

Lim, A.A.T.; Leo, Y.S.; Lee, C.C.; Robinson, A.N., 2001:
Oral manifestations of human immunodeficiency virus (HIV)-infected patients in Singapore

D.C.ster, P.J.A.; Martens, L.C.M.; D.P.epe, A., 2002:
Oral manifestations of patients with Marfan syndrome: A case-control study

Szilagyi, A.; Keszthelyi, G.; Nagy, G.; Madlena, M., 2000:
Oral manifestations of patients with Turner syndrome

Atkinson, J.C.; O'Connell, A.; Aframian, D., 2000:
Oral manifestations of primary immunological diseases

Sierevogel, M.J.; Pasterkamp, G.; Velema, E.; de Jaegere, P.P.; de Smet, B.J.; Verheijen, J.H.; de Kleijn, D.P.; Borst, C., 2001:
Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: an intravascular ultrasound study in the pig

Beutel, K.; Partsch, C.J.; Jänig, U.; Nikischin, W.; Suttorp, M., 2001:
Oral mature teratoma containing epididymal tissue in a female neonate

Duan-Chunzhi; Li-Jun; Wang-Peijie, 1999:
Oral maxillofacial cystic diseases resected by Nd-YAG laser

Akhtar, A.J., 2003:
Oral medication-induced esophageal injury in elderly patients

Nelson, R.W., 2000:
Oral medications for treating diabetes mellitus in dogs and cats

Thigpen, J.T.; Brady, M.F.; Alvarez, R.D.; Adelson, M.D.; Homesley, H.D.; Manetta, A.; Soper, J.T.; Given, F.T., 1999:
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group

Dreiser, R.L.; L.P.rc, J.M.; Velicitat, P.; Lleu, P.L., 2001:
Oral meloxicam is effective in acute sciatica: Two randomised, double-blind trials versus placebo or diclofenac

Boccadoro, M.; Palumbo, A.; Bringhen, S.; Merletti, F.; Ciccone, G.; Richiardi, L.; Rus, C.; Bertola, A.; Giaccone, L.; Omedè, P.; Musto, P., 2002:
Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

Van Der Waal, R.I.F.; Buter, J.; Van Der Waal, I., 2003:
Oral metastases: Report of 24 cases

Rhind, S.M.; Hawe, C.; Dixon, P.M.; Scudamore, C.L., 1999:
Oral metastasis of renal cell carcinoma in a horse

Wiebe, Ellen, R., 1999:
Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion

Lipscomb, G.H.; Meyer, N.L.; Flynn, D.E.; Peterson, M.; Ling, F.W., 2002:
Oral methotrexate for treatment of ectopic pregnancy

Dippy, J.E.; Collins, D.A.; Price, E.J., 2000:
Oral methotrexate: Hazard of different tablet strengths

Schott, J.M.; Rigby, S.P.; McNally, J.D.; Keat, A.; Higgens, C.S., 1999:
Oral methotrexate: the hazard of different tablet strengths

Barrett, S.P.; Pihl, R.O., 2002:
Oral methylphenidate-alcohol co-abuse

Ransom, S.B.; McComish, J.F.; Greenberg, R.; Tolford, D.A., 1999:
Oral metronidazole vs. Metrogel Vaginal for treating bacterial vaginosis. Cost-effectiveness evaluation

Almstahl, A.; Kroneld, U.; Tarkowski, A.; Wikstrom, M., 1999:
Oral microbial flora in Sjogren's syndrome

Almstahl, A.; Wikstrom, M.; Stenberg, I.; Jakobsson, A.; Fagerberg Mohlin, B., 2003:
Oral microbiota associated with hyposalivation of different origins

Navazo, L.; Salata, H.; Morales, S.; Dorta, M.C.; Pérez, F.; de las Casas, D.; Avilés, J., 2001:
Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis

Almståhl, A.; Wikström, M., 1999:
Oral microflora in subjects with reduced salivary secretion

Brosius, K.K.; Bannister, C.F., 2002:
Oral midazolam premedication in preadolescents and adolescents

Bartha, J.L.; Comino Delgado, R.; Garcia Benasach, F.; Martinez Del Fresno, P.; Moreno Corral, L.J., 2000:
Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: A randomized comparison

Perrone, J.F.; Caldito, G.; Mailhes, J.B.; Tucker, A.N.; Ford, W.R.; London, S.N., 2002:
Oral misoprostol before office endometrial biopsy

Caliskan, E.; Dilbaz, B.; Meydanli, M.M.tlu; Ozturk, N.; Narin, M.A.i; Haberal, A., 2003:
Oral misoprostol for the third stage of labor: A randomized controlled trial

Surbek, D.V.; Fehr, P.M.; Hosli, I.; Holzgreve, W., 1999:
Oral misoprostol for third stage of labor: A randomized placebo-controlled trial

Dallenbach, P.; Boulvain, M.; Viardot, C.; Irion, O., 2003:
Oral misoprostol or vaginal dinoprostone for labor induction: A randomized controlled trial

Gherman, R.B.; Browning, J.; O'Boyle, A.; Goodwin, T.M., 2001:
Oral misoprostol vs. intravaginal prostaglandin E2 for preinduction cervical ripening. A randomized trial

Edelman, J.M.; Turpin, J.A.; Bronsky, E.A.; Grossman, J.; Kemp, J.P.; Ghannam, A.F.; Delucca, P.T.; Gormley, G.J.; Pearlman, D.S., 2000:
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction: A randomized, double-blind trial

Grieco, A.J.; Burstein-Stein, J., 2000:
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction

Malmstrom, K.; Rodriguez Gomez, G.; Guerra, J.; Villaran, C.; Pineiro, A.; Wei, L.X.; Seidenberg, B.C.; Reiss, T.F.; Montelukast/Beclomethasone Study Group, 1999:
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial

Petitpretz, P.; Arvis, P.; Marel, M.; Moita, J.; Urueta, J., 2001:
Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

S.Y.n Wei; Shen Hui Feng, 2000:
Oral mucoadhesive drug delivery system

Poole, P.J.; Black, P.N., 2001:
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

Meller, A.T.; Rumjanek, V.M.; Sansone, C.; Allodi, S., 2002:
Oral mucosa alterations induced by cyclosporin in mice: Morphological features

Petrova, L.V.; Kushlinsky, N.E.; Makarov, Y., L., 2002:
Oral mucosa as a target of steroid sex hormones

Irsaliev, H.I.; Yunuskhuzhaev, P.Y.; Baibekov, A.I.; Eshonova, D.I., 1998:
Oral mucosa changes in exposure to low intensity laser irradiation

Urazova, R.Z.; Shamsutdinov, N.S.; Kazantseva, T.Y., 2002:
Oral mucosa state in children with diseases associated with Helicobacter pylori

Chou, L.L.; Epstein, J.; Cassol, S.A.; West, D.M.; He, W.; Firth, J.D., 2000:
Oral mucosal Langerhans' cells as target, effector and vector in HIV infection

Zhang, J.; Niu, S.; Zhang, H.; Streisand, J.B., 2002:
Oral mucosal absorption of midazolam in dogs is strongly pH dependent

Miyazaki, S.; Kawasaki, N.; Nakamura, T.; Iwatsu, M.; Hayashi, T.; Hou, W.M.; Attwood, D., 2000:
Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and in vivo evaluation

Heckmann, S.M.; Heckmann, J.G.; Hiiz, M.J.; Popp, M.; Marthol, H.; Neundoerfer, B.; Hummel, T., 2001:
Oral mucosal blood flow in patients with burning mouth syndrome

Homma, Y.; Ichinohe, T.; Kaneko, Y., 1999:
Oral mucosal blood flow, plasma epinephrine and haemodynamic responses after injection of lidocaine with epinephrine during midazolam sedation and isoflurane anaesthesia

Kleinegger, C.L.; Hammond, H.L.; Finkelstein, M.W., 2000:
Oral mucosal hyperpigmentation secondary to antimalarial drug therapy

Seidel, B.M.; Schulze, B.; Schubert, S.; Borte, M., 2000:
Oral mucosal immunocompetence in preterm infants in the first 9 months of life

Campisi, G.; Margiotta, V., 2001:
Oral mucosal lesions and risk habits among men in an Italian study population

Lin, H.C.; Corbet, E.F.; Lo, E.C.M., 2001:
Oral mucosal lesions in adult Chinese

Squier, C.A.; Kremer, M.J.; Bruskin, A.; Rose, A.; Haley, J.D., 1999:
Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro

Sonis, S.T.; Oster, G.; Fuchs, H.; Bellm, L.; Bradford, W.Z.; Edelsberg, J.; Hayden, V.; Eilers, J.; Epstein, J.B.; LeVeque, F.G.; Miller, C.; Peterson, D.E.; Schubert, M.M.; Spijkervet, F.K.; Horowitz, M., 2001:
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

Dogru, S.T.; Calis, S.; Oner, F., 2000:
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: In vitro-in vivo evaluation

Bergasa, N.V.; Alling, D.W.; Talbot, T.L.; Wells, M.C.; Jones, E.A.thony, 1999:
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study

Meissner, W.; Schmidt, U.; Hartmann, M.; Kath, R.; Reinhart, K., 2000:
Oral naloxone reverses opioid-associated constipation

Lambon Ralph, M.A.; Cipolotti, L.; Patterson, K., 1999:
Oral naming and oral reading: Do they speak the same language?

Gensler, H.L.; Williams, T.; Huang, A.C.; Jacobson, E.L., 1999:
Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice

Larmon, J.E.aine; Ross, B.S.; May, W.L.; Dickerson, G.A.; Fischer, R.G.; Morrison, J.C., 1999:
Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor

Boulinguez, S.; Sommet, A.; Bedane, C.; Viraben, R.; Bonnetblanc, J.M., 2003:
Oral nicorandil-induced lesions are not aphthous ulcers

Liu, R.; Kurose, T.; Matsukura, S., 2001:
Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats

Angulo, P.; Bharucha, A.E.; Jorgensen, R.A.; Desotel, C.K.; Sandborn, W.J.; Larusso, N.F.; Lindor, K.D., 1999:
Oral nicotine in treatment of primary sclerosing cholangitis: A pilot study

Carossa, S.; Pera, P.; Doglio, P.; Lombardo, S.; Colagrande, P.; Brussino, L.; Rolla, G.; Bucca, C., 2001:
Oral nitric oxide during plaque deposition

Verma, S.; Kirkwood, B.; Brown, S.; Giaffer, M.H., 2000:
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease

Jokela, R.; Koivuranta, M.; Kangas Saarela, T.; Purhonen, S.; Alahuhta, S., 2002:
Oral ondansetron, tropisetron or metoclopramide to prevent postoperative nausea and vomiting: A comparison in high-risk patients undergoing thyroid or parathyroid surgery

Risinger, F.O.; Doan, A.M.; Vickrey, A.C.ryn, 1999:
Oral operant ethanol self-administration in 5-HT1b knockout mice

Rowbotham, M.C.; Twilling, L.; Davies, P.S.; Reisner, L.; Taylor, K.; Mohr, D., 2003:
Oral opioid therapy for chronic peripheral and central neuropathic pain

Weisbach, V.; Skoda, P.; Rippel, R.; Lauer, G.; Glaser, A.; Zingsem, J.; Zimmermann, R.; Eckstein, R., 1999:
Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: A randomized, controlled study

Giannini, E.; Botta, F.; Romagnoli, P.; Testa, R., 2000:
Oral or intravenous lidocaine administration to perform megx test?

Whitley, R.J.; Hayden, F.G.; Reisinger, K.S.; Young, N.; Dutkowski, R.; Ipe, D.; Mills, R.G.; Ward, P., 2001:
Oral oseltamivir treatment of influenza in children

Richter, J.E.; Bochenek, W.; Pantoprazole, U.G.rd Study Group, 2000:
Oral pantoprazole for erosive esophagitis: A placebo-controlled, randomized clinical trial

Nair, N.D.vakaran; Harshan, K.R.; Ramachandran, K.M.; George, P.O., 1996:
Oral papilloma and mucinous adenoma of the stomach in an African Baboon (Papio cycnocephalus)

Lalueza Fox, C.; Gonzalez Martin, A., 1999:
Oral pathology on the Iberian Peninsula and Balearic Islands from the Mesolithic to present times

Musa, N.J.; Kumar, V.; Humphreys, L.; Aguirre, A.; Neiders, M.E., 2002:
Oral pemphigoid masquerading as necrotizing ulcerative gingivitis in a child

Muhammad, J.K.; Lewis, M.A.O.; Crean, S.J.hn, 2002:
Oral pemphigus vulgaris occurring during pregnancy

Sirois, D.; Leigh, J.E.; Sollecito, T.P., 2000:
Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis

Mignogna, M.D.; L.M.zio, L.; Mignogna, R.E.; Carbone, R.; Ruoppo, E.; Bucci, E., 2000:
Oral pemphigus: Long term behaviour and clinical response to treatment with deflazacort in sixteen cases

Marschutz, M.K.; Bernkop Schnurch, A., 2000:
Oral peptide drug delivery: Polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro

Sharma, V.K.; Peyton, B.; Spears, T.; Raufman, J.P.; Howden, C.W., 2000:
Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate

Edgar, T.S., 2003:
Oral pharmacotherapy of childhood movement disorders

Loder, E.; Biondi, D., 2003:
Oral phenobarbital loading: A safe and effective method of withdrawing patients with headache from butalbital compounds

Czeizel, A.E.; Rockenbauer, M.; Olsen, J.; Sørensen, H.T., 2000:
Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study

Yamaguchi, T.; Baxter, J.G.; Maebashi, N.; Asano, T., 1999:
Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats

McGeary, S.P.; Studen-Pavlovich, D.; Ranalli, D.N., 2002:
Oral piercing in athletes: implications for general dentists

Porter, S.R.; Dios, P.D.z; Kumar, N.; Stock, C.; Barrett, A.W.; Scully, C., 1999:
Oral plasmablastic lymphoma in previously undiagnosed HIV disease

Swennen, B.; Levy, J., 2001:
Oral poliomyelitis vaccine: Time to change?

Harkany, T.; Mulder, J.; Horvath, K.M.; Keijser, J.; Van-Der-Meeberg, E.K.; Nyakas, C.; Luiten, P.G.M., 2001:
Oral post-lesion administration of 5-HT1A receptor agonist repinotan hydrochloride (Bay X 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis

Nagao, T.; Warnakulasuriya, S.; Gelbier, S.; Yuasa, H.; Tsuboi, S.; Nakagaki, H., 2003:
Oral pre-cancer and the associated risk factors among industrial workers in Japan's overseas enterprises in the UK

Funk, W.; Jakob, W.; Riedl, T.; Taeger, K., 2000:
Oral preanaesthetic medication for children: double-blind randomized study of a combination of midazolam and ketamine vs midazolam or ketamine alone

Blanco Carrion, A.; Velasco Ortega, E.; Lopez Lopez, J.; Gandara Rey, J.M., 1998:
Oral precancer in the elderly patient

Abdelsayed, R.A.; Sumner, T.; Allen, C.M.; Treadway, A.; Ness, G.M.; Penza, S.L., 2002:
Oral precancerous and malignant lesions associated with graft-versus-host disease: Report of 2 cases

Ruohola, A.; Heikkinen, T.; Jero, J.; Puhakka, T.; Juven, T.; Narkio Makela, M.; Saxen, H.; Ruuskanen, O., 1999:
Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes

Cameron, E.A.B.; Binnie, J.A.H.; Balan, K.; Skerratt, S.A.; Swift, A.; Solanki, C.; Middleton, S.J., 2003:
Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis

Tamura, M.; Nakamura, K.; Kitamura, R.; Kitagawa, S.; Mori, N.; Ueda, Y., 2003 :
Oral premedication with fentanyl may be a safe and effective alternative to oral midazolam

Heine, G.H.; Weindler, J.; Gabriel, H.H.W.; Kindermann, W.; Ruprecht, K.W., 2003:
Oral premedication with low dose midazolam modifies the immunological stress reaction after the setting of retrobulbar anaesthesia

Pihl, A.; Bruland, O.S., 2000:
Oral presentations in science and medicine. An art in decline?

Ray, N.B.; Krieg, A.M., 2003:
Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes

Prinz, M.; Huber, G.; Macpherson, A.J.S.; Heppner, F.L.; Glatzel, M.; Eugster, H-Pietro.; Wagner, N.; Aguzzi, A., 2003:
Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes

Bernard, P.; Chosidow, O.; Vaillant, Lïc., 2002:
Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial

Wu, F.C.; Balasubramanian, R.; Mulders, T.M.; Coelingh-Bennink, H.J., 1999:
Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism

Cavallini, G.; Biagiotti, G.; Koverech, A.; Vitali, G., 2002:
Oral propionyl-L-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease

Oota, S.; Shibuya, H.; Hamagaki, M.; Yoshimura, R-ichi.; Iwaki, H.; Kojima, M.; Takagi, M., 2003:
Oral pseudotumor: benign polypoid masses following radiation therapy

Van Der Meulen, M.F.G.; Hoogendijk, J.E.; Wokke, J.H.J.; D.V.sser, M., 2000:
Oral pulsed high-dose dexamethasone for myositis

Ondrejka, R.; Ondrejkova, A.; Svrcek, S.; Benisek, Z.; Suli, J.; Zavadova, J.; Madar, M.; Mojzisova, J., 2001:
Oral rabies immunization of swine: Use of Vnukovo-32/107 vaccination strain

Kawahara, M.; Hashimoto, A.; Toida, I.; Honda, M., 2002:
Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity

Gomez, R.S.; Carneiro, M.A.; Souza, L.N.; Victória, J.M.; de Azevedo, W.M.; De Marco, L.; Kalapothakis, E., 2001:
Oral recurrent human herpes virus infection and bone marrow transplantation survival

Chong, W.L.; Chu, S.A.; Dam, J.G.; Ong, K.S., 1999:
Oral rehabilitation using dental implants and guided bone regeneration

Caeiro, J.P.; DuPont, H.L.; Albrecht, H.; Ericsson, C.D., 1999:
Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea

Makhlouf, K.; Comabella, M.; Imitola, J.; Weiner, H.L.; Khoury, S.J., 2001:
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis

Grathwohl, C.; Dadmarz, M.; Vogel, W.H., 2001:
Oral self-administration of ethanol and cocaine in rats

Vivian, J.A.; Liang, Y.J.; Higley, J.D.; Linnoila, M.; Woods, J.H., 1999:
Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys

Karikoski, A.; Ilanne Parikka, P.; Murtomaa, H., 2001:
Oral self-care and periodontal health indicators among adults with diabetes in Finland

Verri, A.; Uggetti, C.; Vallero, E.; Ceroni, M.; Federico, A., 2000:
Oral self-mutilation in a patient with rhombencephalosynapsys

Danilova, V.; Hellekant, G., 2002:
Oral sensation of ethanol in a primate model III: Responses in the lingual branch of the trigeminal nerve of Macaca mulatta

Okunuki, H.; Teshima, R.; Harikai, N.; Sakai, S.; Akiyama, H.; Maitani, T.; Sawada, J-Ichi., 2003:
Oral sensitization of W/W(v) mice with ovalbumin and possible involvement of the decrease in gammadelta-T cells

Nishida, Y.; Yoshie, S.; Fujita, T., 2000:
Oral sensory papillae, chemo- and mechano-receptors, in the snake, Elaphe quadrivirgata. A light and electron microscopic study

Gottlieb, S., 2000:
Oral sex may be important risk factor for HIV infection

Barber, R.; Delahunt, B.; Grebe, S.K.; Davis, P.F.; Thornton, A.; Slim, G.C., 2001:
Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model

Ghofrani, H.A.; Rose, F.; Schermuly, R.T.; Olschewski, H.; Wiedemann, R.; Kreckel, A.; Weissmann, N.; Ghofrani, S.; Enke, B.; Seeger, W.; Grimminger, F., 2003:
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

Michelakis, E.; Tymchak, W.; Lien, D.; Webster, L.; Hashimoto, K.; Archer, S., 2002:
Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide

Szeto, C-Chun.; Wong, T.Yuk-Hwa.; Chow, K-Ming.; Leung, C-Bon.; Li, P.Kam-Tao., 2003:
Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial

Rasmussen, M.; Bohlbro, K.; Qvist, N., 2003:
Oral sodium phosphate compared with water enemas combined with Bisacodyl as bowel preparation for elective colonoscopy

Barasch, A.; Safford, M.M.; Catalanotto, F.A.; Fine, D.H.; Katz, R.V., 2000:
Oral soft tissue manifestations in HIV-positive vs. HIV-negative children from an inner city population: a two-year observational study

Jordan, R.C.K.; Regezi, J.A., 2003:
Oral spindle cell neoplasms: a review of 307 cases

Fracchioli, S.; Porpiglia, M.; Arisio, R.; Voglino, G.; Katsaros, D., 2003:
Oral squamous carcinoma in a patient with cervix cancer: Use of human papillomavirus analysis to differentiate synchronous versus metastatic tumor

Schwartz, S.M.; Doody, D.R.; Fitzgibbons, E.D.; Ricks, S.; Porter, P.L.; Chen, C., 2001:
Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes

Loro, L.L.ko; Vintermyr, O.K.rsten; Liavaag, P.G.nnar; Jonsson, R.; Johannessen, A.C.ristine, 1999:
Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis

D.V.cente, J.C.rlos; Recio, O.R.driguez; Pendas, S.L.orente; Lopez Arranz, J.S.bastian, 2001:
Oral squamous cell carcinoma of the mandibular region: A survival study

Tanaka, N.; Sugihara, K.; Odajima, T.; Mimura, M.; Kimijima, Y.; Ichinose, S., 2002:
Oral squamous cell carcinoma: electron microscopic and immunohistochemical characteristics

Gibson, J.; Wray, D.; Bagg, J., 2000:
Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease

Edwards, C.J.; Hart, D.J.; Spector, T.D., 2000:
Oral statins and increased bone-mineral density in postmenopausal women

Schuller, A.A.; Holst, D., 2001:
Oral status indicators DMFT and FS-T: Reflections on index selection

Hui, A.C.; Wong, S.M.; Wong, K.S.; Li, E.; Kay, R.; Yung, P.; Hung, L.K.; Yu, L.M., 2001:
Oral steroid in the treatment of carpal tunnel syndrome

Park, M.H.; Starling, R.C.; Ratliff, N.B.; Mccarthy, P.M.; Smedira, N.S.; Pelegrin, D.; Young, J.B., 1999:
Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection

Schothorst, R.C.; Jekel, A.A., 1999:
Oral sterol intake in The Netherlands: Evaluation of the results obtained by GC analysis of duplicate 24-h diet samples collected in 1994

Dancer, S.J.; Robb, A.; Crawford, A.; Morrison, D., 2003:
Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections

Takenaka, I.; Aoyama, K.; Nakamura, M.; Fukuyama, H.; Urakami, Y.; Takenaka, Y.; Kadoya, T., 2002:
Oral styletted intubation under video control in a patient with a large mobile glottic tumour and a difficult airway

Haque, M.F.; Meghji, S.; Khitab, U.; Harris, M., 2000:
Oral submucous fibrosis patients have altered levels of cytokine production

Gambaro, G.; Kinalska, I.; Oksa, A.; Pont'uch, P.; Hertlová, M.; Olsovsky, J.; Manitius, J.; Fedele, D.; Czekalski, S.; Perusicová, J.; Skrha, J.; Taton, J.; Grzeszczak, W.; Crepaldi, G., 2002:
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

Sramek, J.J.; Hussey, E.K.; Clements, B.; Cutler, N.R., 1999:
Oral sumatriptan pharmacokinetics in the migraine state

Iijima, S.; Otsuka, F.; Kikuchi, H.; Yamada, K.; Nakajima, T.; Yahiro, K.; Kondo, A., 2000:
Oral supplementation with gamma-linolenic acid extracted from Mucor circinelloides improves the deformability of red blood cells in hemodialysis patients

Scully, C.; Wolff, A., 2002:
Oral surgery in patients on anticoagulant therapy

Kubo, W.; Miyazaki, S.; Attwood, D., 2003:
Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations

Miyazaki, S.; Kawasaki, N.; Endo, K.; Attwood, D., 2001:
Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits

Miyazaki, S.; Kubo, W.; Attwood, D., 2000:
Oral sustained delivery of theophylline using in-situ gelation of sodium alginate

Nicolaos, G.; Burnel, S.; Letallieur, M.; Hiesse, C.; Aubert, P.; Pruna, A., 1998:
Oral switch of cyclosporin A in renal transplantation

Collin, H.L.; Niskanen, L.; Uusitupa, M.; Töyry, J.; Collin, P.; Koivisto, A.M.; Viinamäki, H.; Meurman, J.H., 2000:
Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy

Rhodus, N.L.; Fricton, J.; Carlson, P.; Messner, R., 2003:
Oral symptoms associated with fibromyalgia syndrome

Meer, S.; Coleman, H.; Altini, M., 2003:
Oral synovial sarcoma: A report of 2 cases and a review of the literature

Ierardi, E.; Principi, M.; Francavilla, R.; Pisani, A.; Rendina, M.; Ingrosso, M.; Guglielmi, F.W.; Panella, C.; Francavilla, A., 2001:
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance

Kim, D.Joo.; Kim, T.Il.; Suh, J.Hoon.; Cho, Y.Suk.; Shin, S.Kwan.; Kang, J.Kyung.; Kim, N.Kyu.; Kim, W.Ho., 2003:
Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer

Zervos, M.J.; Heyder, A.M.; Leroy, B., 2003:
Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis

Takahashi, N.; Kawamura, M., 2001:
Oral tendency due to frontal lobe lesion

Heesen, C.; Gold, S., M.; Sondermann, J.; Tessmer, W.; Schulz, K.-Heinz, 2002:
Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls

Peng, S.H.; Segura, J.; Farré, M.; de la Torre, X., 2000:
Oral testosterone administration detected by testosterone glucuronidation measured in blood spots dried on filter paper

Johnson, L.R.; Wood, R.I., 2001:
Oral testosterone self-administration in male hamsters

Wood, R.I., 2002:
Oral testosterone self-administration in male hamsters: dose-response, voluntary exercise, and individual differences

Tfelt-Hansen, P.; Ryan, R.E., 2000:
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials

Raymond, R.S.; Fallon, M.B.; Abrams, G.A., 1998:
Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial

Wajima, Z'ichiro.; Yoshikawa, T.; Ogura, A.; Imanaga, K.; Shiga, T.; Inoue, T.; Ogawa, R., 2002:
Oral tizanidine, an alpha2-adrenoceptor agonist, reduces the minimum alveolar concentration of sevoflurane in human adults

Kang, B.; Kim, K.M.; Kang, C.Y., 1999:
Oral tolerance by a high dose OVA in BALB/c mice is more pronounced and persistent in Th2-mediated immune responses than in Th1 responses

Pecquet, S.; Leo, E.; Fritsché, R.; Pfeifer, A.; Couvreur, P.; Fattal, E., 2000:
Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres

Garside, P.; Mowat, A.M.; Khoruts, A., 1999:
Oral tolerance in disease

Jung, S.; Gaupp, S.; Hartung, H.-Peter; Toyka, K., V., 2001:
Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat: II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN

Faria, A.M.C.; Maron, R.; Ficker, S.M.; Slavin, A.J.; Spahn, T.; Weiner, H.L., 2003:
Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis

Sato, M.N.; Fusaro, A.E.; Victor, J.R.; Oliveira, C.R.; Futata, E.T.; Maciel, M.; Carvalho, A.F.; Duarte, A.J., 2001:
Oral tolerance induction in dermatophagoides pteronyssinus-sensitized mice induces inhibition of IgE response and upregulation of TGF-beta secretion

Maron, R.; Slavin, A.J.; Hoffmann, E.; Komagata, Y.; Weiner, H.L., 2002:
Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines

López, M.C.; Márquez, M.G.; Slobodianik, N.H.; Roux, M.E., 2003:
Oral tolerance to dextrin mediated by specific suppressor T-cells induced in the intestinal intraepithelium and their systemic migration

Thurau, S.R.; Diedrichs Moehring, M.; Fricke, H.; Burchardi, C.; Wildner, G., 1999:
Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis

Weiner, H.L., 2000:
Oral tolerance, an active immunologic process mediated by multiple mechanisms

Weiner, Howard, L., 2001:
Oral tolerance: Immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

Nagler, A.; Pines, M.; Abadi, U.; Pappo, O.; Zeira, M.; Rabbani, E.; Engelhardt, D.; Ohana, M.; Chowdhury, N.R.; Chowdhury, J.R.; Ilan, Y., 2000:
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

O'Malley, R.C.; McGrew, W.C., 2000:
Oral tool use by captive orangutans (Pongo pygmaeus)

Johnson, B.A.; Ait-Daoud, N.; Bowden, C.L.; DiClemente, C.C.; Roache, J.D.; Lawson, K.; Javors, M.A.; Ma, J.Z., 2003:
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

Gelderblom, H.A.J.; D.J.nge, M.J.A.; Sparreboom, A.; Verweij, J., 1999 :
Oral topoisomerase 1 inhibitors in adult patients: Present and future

Clarke-Pearson, D.L.; Van Le, L.; Iveson, T.; Whitney, C.W.; Hanjani, P.; Kristensen, G.; Malfetano, J.H.; Beckman, R.A.; Ross, G.A.; Lane, S.R.; DeWitte, M.H.; Fields, S.Z., 2001:
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer

Brown, A.P.; Morrissey, R.L.; Tolhurst, T.A.; Crowell, J.A.; Levine, B.S., 2000:
Oral toxicity of 1,2-dithiole-3-thione, a potential cancer chemopreventive agent, in the rat

Waterfield, N.; Dowling, A.; Sharma, S.; Daborn, P.J.; Potter, U.; Ffrench-Constant, R.H., 2001:
Oral toxicity of Photorhabdus luminescens W14 toxin complexes in Escherichia coli

Humpage, A.R.; Falconer, I.R., 2003:
Oral toxicity of the cyanobacterial toxin cylindrospermopsin in male Swiss albino mice: determination of no observed adverse effect level for deriving a drinking water guideline value

Roelofse, J.A.; Payne, K.A., 1999:
Oral tramadol: analgesic efficacy in children following multiple dental extractions

Flo, J.; Tisminetzky, S.; Baralle, F., 2001:
Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice

Camandaroba, E.Luiz.P.; Pinheiro Lima, C.M.; Andrade, S.G., 2002:
Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection

Baron, S., 2001:
Oral transmission of HIV, a rarity: emerging hypotheses

Baron, S.; Poast, J.; Richardson, C.J.; Nguyen, D.; Cloyd, M., 2000 :
Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism

Ruprecht, R.M.; Baba, T.W.; Liska, V.; Ray, N.B.; Martin, L.N.; Murphey-Corb, M.; Rizvi, T.A.; Bernacky, B.J.; Keeling, M.E.; McClure, H.M.; Andersen, J., 1999:
Oral transmission of primate lentiviruses

Portenoy, R., K.; Payne, R.; Coluzzi, P.; Raschko, J., W.; Lyss, A.; Busch, M., A.; Frigerio, V.; Ingham, J.; Loesth, D., B.; Nordbrock, E.; Rhiner, M., 1999:
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: A controlled dose titration study

Pandit, U.A.; Collier, P.J.; Malviya, S.; Voepel-Lewis, T.; Wagner, D.; Siewert, M.J., 2001:
Oral transmucosal midazolam premedication for preschool children

Costabile, R.A.; Spevak, M., 1999:
Oral trazodone is not effective therapy for erectile dysfunction: A double-blind, placebo controlled trial

Isaksson, R.; Söderfeldt, Börn.; Nederfors, T., 2003:
Oral treatment need and oral treatment intention in a population enrolled in long-term care in nursing homes and home care

George, S.E.; Nelson, G.M.; Kohan, M.J.; Warren, S.H.; Eischen, B.T.; Brooks, L.R., 2001:
Oral treatment of Fischer 344 rats with weathered crude oil and a dispersant influences intestinal metabolism and microbiota

Altwein, J.E.; Keuler, F.U., 2001:
Oral treatment of erectile dysfunction with apomorphine SL

Haus, U.; Varga, B.; Stratz, T.; Spaeth, M.; Mueller, W., 2000:
Oral treatment of fibromyalgia with tropisetron given over 28 days: Influence on functional and vegetative symptoms, psychometric parameters and pain

Aharoni, R.; Meshorer, A.; Sela, M.; Arnon, R., 2002:
Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system

Chowienczyk, P.J.; Brett, S.E.; Gopaul, N.K.; Meeking, D.; Marchetti, M.; Russell-Jones, D.L.; Anggård, E.E.; Ritter, J.M., 2000:
Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes

Semiz, S.; Mcneill, J.H., 2002:
Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity

Asai, Y.; Jinno, T.; Ogawa, T., 2003:
Oral treponemes and their outer membrane extracts activate human gingival epithelial cells through toll-like receptor 2

Ferrari, M.D.; Roon, K.I.; Lipton, R.B.; Goadsby, P.J., 2001:
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

Wolff, J.E.A.; Molenkamp, G.; Westphal, S.; Pietsch, T.; Gnekow, A.; Kortmann, R.D.eter; Kuehl, J., 2000:
Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme

Horvath, V.; Hartlapp, J.H.; Hegewisch Becker, S.; Feyerabend, T.; V.W.ikersthal, L.F.scher; Illiger, H.J.; Jaeger, E.; Peters, S.O.; Reichardt, P.; Uthgenannt, D.; Weber, K.; Wagner, T.; Wiedemann, G.J.; Zschaber, R., 2000:
Oral trofosfamide in elderly and/or heavily pretreated patients with metastatic lung cancer

Douglass, A.; A.M.rdini, H.; Record, C.O., 2003:
Oral tryptophan challenge studies in cirrhotic patients: No evidence of neuropsychiatric changes

Chattopadhyay, A.; Patra, R.; Vijaykumar, 2003:
Oral tumors in newborn

Fierabracci, V.; De Tata, V.; Pocai, A.; Novelli, M.; Barberà, A.; Masiello, P., 2003:
Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes

Barnadas, M.A.; Escartín, A.; Alomar, A., 2000:
Oral ulcerations as the first sign of a foramen magnum meningioma

Syrjanen, S.; Leimola-Virtanen, R.; Schmidt-Westhausen, A.; Reichart, P.A., 1999:
Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections

van Gelder, T.; ter Meulen, C.G.; Hené, R.; Weimar, W.; Hoitsma, A., 2003:
Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil

Wang, Q.; Ma, G.; Lu, H., 1999:
Oral ultrasonic bowel contrast solution to diagnose colorectal tumor

Florence, A.T.; Sakthivel, T.; Toth, I., 2000:
Oral uptake and translocation of a polylysine dendrimer with a lipid surface

Ho, D.H.; Covington, W.; Brown, N.; Lin, S.N.; Pazdur, R.; Huo, Y.Y.; Creaven, P.J.; Rustum, Y.M.; Meropol, N.J.; Lassere, Y.; Kuritani, J.; Hayakawa, T., 2000:
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer

Yang, T-Shen.; Wang, J-Yi.; Tang, R.; Hsu, K-Cheng.; Chen, J-Shi., 2002:
Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer

Reid, G.; Charbonneau, D.; Erb, J.; Kochanowski, B.; Beuerman, D.; Poehner, R.; Bruce, A.W., 2003:
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women

Cummins, J.M.; Beilharz, M.W.; Krakowka, S., 1999:
Oral use of interferon

Tanaka-Kataoka, M.; Kunikata, T.; Takayama, S.; Iwaki, K.; Fujii, M.; Ohashi, K.; Ikeda, M.; Kurimoto, M., 1999:
Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice

Smith, J.K.; Siddiqui, A.A.; Krishnaswamy, G.A.; Dykes, R.; Berk, S.L.; Magee, M.; Joyner, W.; Cummins, J., 1999:
Oral use of interferon-alpha stimulates ISG-15 transcription and production by human buccal epithelial cells

Lazareva, E.B.; Smirnov, S.V.; Khvatov, V.B.; Spiridonova, T.G.; Bitkova, E.E.; Shramko, L.U.; Menshikov, D.D., 2002:
Oral use of pectins for infections prophylaxis at the patients with burns

Gravningen, K.; Kestin, S.; Thorarinsson, R.; Syvertsen, C., 1998:
Oral vaccination against enteric red mouth disease in rainbow trout (Oncorhynchus mykiss Walbaum): The effect of vaccine dose rate on protection against the disease

Brayden, David, J., 2001:
Oral vaccination in man using antigens in particles: Current status

Bowersock, T.L.; Hogenesch, H.; Suckow, M.; Guimond, P.; Martin, S.; Borie, D.; Torregrosa, S.; Park, H.; Park, K., 1999:
Oral vaccination of animals with antigens encapsulated in alginate microspheres

Xiang, Z.Q.; Gao, G.P.; Reyes-Sandoval, A.; Li, Y.; Wilson, J.M.; Ertl, H.C.J., 2003:
Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier

Rose, R.C.; Lane, C.; Wilson, S.; Suzich, J.A.; Rybicki, E.; Williamson, A.L.se, 1999:
Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies

Miller, L.A.; Johns, B.E.; Elias, D.J.; Killian, G.J., 1999:
Oral vaccination of white-tailed deer using a recombinant Bacillus Calmette-Guerin vaccine expressing the Borrelia burgdorferi outer surface protein A: Prospects for immunocontraception

Hermida, G.; Manjón, R.; Casanova, F.; Rodriguez-Salazar, M., 2001:
Oral vaccination with autologous platelets in chronic autoimmune thrombocytopenic purpura

Mowat, A.M.i; Smith, R.E.; Donachie, A.M.; Furrie, E.; Grdic, D.; Lycke, N., 1999:
Oral vaccination with immune stimulating complexes

Lin, C-Wei.; Lee, J-Yi.; Tsao, Y-Ping.; Shen, C-Piao.; Lai, H-Cheng.; Chen, S-Li., 2002:
Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress

Doherty, T.Mark.; Olsen, A.Weinrich.; van Pinxteren, L.; Andersen, P., 2002:
Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

Russell Jones, G.J., 2000:
Oral vaccine delivery

Lopez-Gonzalez, M.A.; Delgado, F., 2000:
Oral vaccine in otosclerosis

D.B.cker, T.L.; Vander Stichele, R.H.; Warie, H.H.; Bogaert, M.G., 2000:
Oral vasoactive medication in intermittent claudication: Utile or futile?

Vecchi, M.; Meucci, G.; Gionchetti, P.; Beltrami, M.; D.M.urizio, P.; Beretta, L.; Ganio, E.; Usai, P.; Campieri, M.; Fornaciari, G.; D.F.anchis, R., 2001:
Oral versus combination mesalazine therapy in active ulcerative colitis: A double-blind, double-dummy, randomized multicentre study

Hoberman, A.; Wald, E.R.; Hickey, R.W.; Baskin, M.; Charron, M.; Majd, M.; Kearney, D.H.; Reynolds, E.A.; Ruley, J.; Janosky, J.E., 1999:
Oral versus initial intravenous therapy for urinary tract infections in young febrile children

Licciardi, F.L.; Kwiatkowski, A.; Noyes, N.L.; Berkeley, A.S.; Krey, L.L.; Grifo, J.A., 1999:
Oral versus intramuscular progesterone for in vitro fertilization: A prospective randomized study

Becker, J.M.; Arora, A.; Scarfone, R.J.; Spector, N.D.; Fontana Penn, M.E.izabeth; Gracely, E.; Joffe, M.D.; Goldsmith, D.P.; Malatack, J.J.ffrey, 1999:
Oral versus intravenous corticosteroids in children hospitalized with asthma

Kern, W.V.; Cometta, A.; D.B.ck, R.; Langenaeken, J.; Paesmans, M.; Gaya, H., 1999:
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy

Gordon, M.N.; Muller, C.D.; Sherman, K.A.; Morgan, D.G.; Azzaro, A.J.; Wecker, L., 1999:
Oral versus transdermal selegiline: Antidepressant-like activity in rats

Fisher, S.A.; Mackenzie, V.P.; Davies, G.A., 2001:
Oral versus vaginal misoprostol for induction of labor: a double-blind randomized controlled trial

Hall, R.; Duarte Gardea, M.; Harlass, F., 2002:
Oral versus vaginal misoprostol for labor induction

Raitakari, O.T.; Adams, M.R.; McCredie, R.J.; Griffiths, K.A.; Stocker, R.; Celermajer, D.S., 2000:
Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect

Crowther, M.A.; Douketis, J.D.; Schnurr, T.; Steidl, L.; Mera, V.; Ultori, C.; Venco, A.; Ageno, W., 2002:
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

Schubiger, G.; Stocker, C.; Banziger, O.; Laubscher, B.; Zimmermann, H., 1999:
Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland

van Rooij, J.; Schwartzenberg, S.G.; Mulder, P.G.; Baarsma, S.G., 1999:
Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients

Marik, P.E.; Varon, J., 2002:
Oral vs inhaled corticosteroids following emergency department discharge of patients with acute asthma

Mombelli, G.; Pezzoli, R.; Pinoja Lutz, G.; Monotti, R.; Marone, C.; Franciolli, M., 1999:
Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections. A prospective randomized clinical trial

Terai, M.; Takagi, M.; Matsukura, T.; Sata, T., 1999:
Oral wart associated with human papillomavirus type 2

Tanko, L.B.; Felsenberg, D.; Czerwinski, E.; Burdeska, A.; Jonkanski, I.; Hughes, C.; Christiansen, C., 2003:
Oral weekly ibandronate prevents bone loss in postmenopausal women

Wallentin, L.; Wilcox, R.G.; Weaver, W.Douglas.; Emanuelsson, Håkan.; Goodvin, A.; Nyström, P.; Bylock, A., 2003:
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Bhadrakom, C.; Simonds, R.J.; Mei, J.V.; Asavapiriyanont, S.; Sangtaweesin, V.; Vanprapar, N.; Moore, K.H.P.; Young, N.L.; Hannon, W.H.rry; Mastro, T.D.; Shaffer, N., 2000:
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: Tolerance and zidovudine concentration in cord blood

A.G.rairi, F.T.; A.W.iz, M.; Sharquie, K.E., 2002:
Oral zinc sulphate in the treatment of recalcitrant viral warts: Randomized placebo-controlled clinical trial

Uckan, D.; Cin, S.; Dincer, N., F.; Yalcin, S.; Cavdar, A., 2001:
Oral zinc tolerance test in pregnant women

Bahra, A.; Gawel, M.J.; Hardebo, J.E.; Millson, D.; Breen, S.A.; Goadsby, P.J., 2000:
Oral zolmitriptan is effective in the acute treatment of cluster headache

Giltay, E.J.; Gooren, L.J.; Emeis, J.J.; Kooistra, T.; Stehouwer, C.D., 2000:
Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis

Ferrero, G.Battista.; Valenzise, M.; Franco, B.; Defilippi, C.; Gregato, G.; Corsello, G.; Pepe, E.; Silengo, M., 2002:
Oral, facial, digital, vertebral anomalies with psychomotor delay: a mild form of OFD type Gabrielli?

French, S., J.; Cecil, J., E., 2001:
Oral, gastric and intestinal influences on human feeding

Nemes, K.B.logh; Abermann, M.; Bojti, E.; Grezal, G.; A.B.haisi, S.; Klebovich, I., 2000:
Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat

Mccluskie, M.J.; Davis, H.L., 2000:
Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

Downey, D.; Spencer, S.J.; Deghenghi, R.; Jaffe, R.B., 2001:
Oral, water-soluble combined estrogen/calcium preparation for postmenopausal therapy

Obregón, M.Gabriela.; Barreiro, C.Zulema., 2003:
Oral-facial-digital syndrome gabrielli type: second report

Coffman, J.A.; Davidson, E.H., 2001:
Oral-aboral axis specification in the sea urchin embryo. I. Axis entrainment by respiratory asymmetry

Punthakee, X.; Doobay, J.; Anand, S.S., 2002:
Oral-anticoagulant-related intracerebral hemorrhage

Masuda, K.; Horie, K.; Suzuki, R.; Yoshikawa, T.; Hirano, K., 2003:
Oral-antigen delivery via a water-in-oil emulsion system modulates the balance of the Th1/Th2 type response in oral tolerance

Michaëlsson, K.; Baron, J.A.; Farahmand, B.Y.; Persson, I.; Ljunghall, S., 1999:
Oral-contraceptive use and risk of hip fracture: a case-control study

Ghossaini, S.N.; Hadi, U.; Tawil, A., 2002:
Oral-facial-digital syndrome type II variant associated with congenital tongue lipoma

Hsieh, Y.C.ia; Hou, Jia Woei, 1999:
Oral-facial-digital syndrome with Y-shaped fourth metacarpals and endocardial cushion defect

Fujiwara, I.; Kondo, Y.; IInuma, K., 1999:
Oral-facial-digital syndrome with hypothalamic hamartoma, postaxial ray hypoplasia of the limbs, and vagino-cystic communication: A new variant?

Reilly, S.M.; Skuse, D.H.; Wolke, D.; Stevenson, J., 1999:
Oral-motor dysfunction in children who fail to thrive: Organic or non-organic?

Ishihama, K.; Kogo, M.; Koizumi, H.; Nomura, K.; Tanaka, S.; Yamanishi, T.; Enomoto, A., 2003 :
Oral-motor patterns of rhythmic trigeminal activity generated in fetal rat brainstem in vitro

Dutta, S.; Cloyd, J.C.; Granneman, G.R.chard; Collins, S.D., 2003:
Oral/intravenous maintenance dosing of valproate following intravenous loading: A simulation

Kern, B.; Lahrmann, K.H., 2000:
Orale Immunisierung gegen die klassische Schweinepest (KSP) beim Schwarzwild im Land Brandenburg von 1995 bis 1997

Sievert, K.D.; Edenfeld, K.D.; Oberpenning, F.; Piechota, H.J., 2000:
Orale Therapie der interstitiellen Zystitis

Kitamura, S.; Fukushi, H.; Miyawaki, T.; Kawamura, M.; Terashita, Z.-Ichi; Naka, T., 2001:
Orally active GPIIb/IIIa antagonists: Synthesis and biological activities of masked amidines as prodrugs of 2-((3S)-4-((2S)-2-(4-amidinobenzoylamino)-3-(4-methoxyphenyl)propanoyl)-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl)acetic acid

Venhuis, B., J.; Dijkstra, D.; Wustrow, D., J.; Meltzer, L., T.; Wise, L., D.; Johnson, S., J.; Heffner, T., G.; Wikstrom, H., V., 2003:
Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: Synthesis and pharmacological activity

Boyle, C.D.; Lachowicz, J.E., 2002:
Orally active and selective benzylidene ketal M2 muscarinic receptor antagonists for the treatment of Alzheimer's disease

Yamamoto, H.; Eikyu, Y.; Okuda, S.; Kawabata, K.; Takasugi, H.; Tanaka, H.; Matsumoto, S.; Matsumoto, Y.; Tawara, S., 2002:
Orally active cephalosporins. Part 4: Synthesis, structure-activity relationships and oral absorption of novel 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains

IImura, S.; Uoto, K.; Ohsuki, S.; Chiba, J.; Yoshino, T.; Iwahana, M.; Jimbo, T.; Terasawa, H.; Soga, T., 2001:
Orally active docetaxel analogue: Synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues

Hulme, C.; Mathew, R.; Moriarty, K.; Miller, B.; Ramanjulu, M.; Cox, P.; Souness, J.; Page, K.M.; Uhl, J.; Travis, J.; Labaudiniere, R.; Huang, F.C.ih; Djuric, S.W., 1998:
Orally active indole N-oxide PDE4 inhibitors

Balasubramanyam, M.; Mohan, V., 2001:
Orally active insulin mimics: Where do we stand now?

Olson, R.E.; Sielecki, T.M.; Wityak, J.; Pinto, D.J.; Batt, D.G.; Frietze, W.E.; Liu, J.; Tobin, A.E.; Orwat, M.J.; Di Meo, S.V.; Houghton, G.C.; Lalka, G.K.; Mousa, S.A.; Racanelli, A.L.; Hausner, E.A.; Kapil, R.P.; Rabel, S.R.; Thoolen, M.J.; Reilly, T.M.; Anderson, P.S.; Wexler, R.R., 1999:
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action

Venhuis, B.J.; Dijkstra, D.; Wustrow, D.; Meltzer, L.T.; Wise, L.D.; Johnson, S.J.; Wikström, Håkan.V., 2003:
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity